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orchestrated by cytokines and CD4+ helper T (Th) cells. The Notch signaling pathway plays a critical role
both in the generation of the T cell repertoire and in Th cell differentiation. However, while Notch is well
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Notch regulates the differentiation of a common naÃ¯ve progenitor into one of the many Th cell subsets.
To clarify the molecular mechanism used by Notch to influence Th cell differentiation, the dynamics of
Notch target binding and gene regulation were analyzed at early time points after T cell activation. Rather
than finding that Notch signaling acts via the canonical instructional paradigm, these studies find that
Notch acts as an unbiased integrator of environmental differentiation cues, such that it simultaneously
promotes the differentiation of multiple inflammatory Th cell populations. These findings are supported
by in vivo gain-of-function studies in which Notch signaling is constitutively activated in peripheral T cells.
Unlike previous work showing that hyper-activation of the Notch pathway in T lineage progenitors yields
aggressive T cell acute lymphoblastic leukemia, these mice go on to develop a lethal autoinflammatory
disorder, resulting from the Notch pathway promoting the differentiation of Th1, Th2, and Th17 cells.
Additionally, these studies reveal that Notch signaling acts to destabilize regulatory T cell differentiation.
Altogether, the work presented in this thesis evinces a novel non-instructional paradigm for Notch
signaling, with broad implications for our understanding of Th cell differentiation, hematopoietic
development, and cancer biology.
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ABSTRACT
NON-INSTURCTIONAL ROLES FOR NOTCH SIGNALING IN T CELL DEVELOPMENT
Will Harrison Bailis
Warren S. Pear

Mammalian immunity requires the presence of a broad and diverse repertoire of antigen
receptors that can recognize the virtually infinite number of pathogenic epitopes
encountered over a lifetime of a host, along with the ability to flexibly mount organized
and pathogen-specific immune responses, as orchestrated by cytokines and CD4+
helper T (Th) cells. The Notch signaling pathway plays a critical role both in the
generation of the T cell repertoire and in Th cell differentiation. However, while Notch is
well understood to instruct early T lineage development at the expense of alternate
lineages, it is unclear how Notch regulates the differentiation of a common naïve
progenitor into one of the many Th cell subsets. To clarify the molecular mechanism
used by Notch to influence Th cell differentiation, the dynamics of Notch target binding
and gene regulation were analyzed at early time points after T cell activation. Rather
than finding that Notch signaling acts via the canonical instructional paradigm, these
studies find that Notch acts as an unbiased integrator of environmental differentiation
cues, such that it simultaneously promotes the differentiation of multiple inflammatory Th
cell populations. These findings are supported by in vivo gain-of-function studies in
which Notch signaling is constitutively activated in peripheral T cells. Unlike previous
work showing that hyper-activation of the Notch pathway in T lineage progenitors yields
aggressive T cell acute lymphoblastic leukemia, these mice go on to develop a lethal
autoinflammatory

disorder,

resulting

from
ii

the

Notch

pathway

promoting

the

differentiation of Th1, Th2, and Th17 cells. Additionally, these studies reveal that Notch
signaling acts to destabilize regulatory T cell differentiation. Altogether, the work
presented in this thesis evinces a novel non-instructional paradigm for Notch signaling,
with broad implications for our understanding of Th cell differentiation, hematopoietic
development, and cancer biology.
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CHAPTER 1: Introduction
The mammalian immune system is faced with the daunting challenge of generating a T
cell receptor (TCR) repertoire large enough to cover every potential antigen a host will
encounter in their lifetime from a limited number of progenitors. To accomplish this task,
the few progenitors that enter the thymus must expand by several orders of magnitude in
order to generate sufficient genetic material to survive antigen receptor recombination
and TCR selection. Even after this is accomplished and a mature T cell enters the
periphery, it will need to further differentiate to acquire its effector function. As cognate
antigen recognition alone is not sufficient to clear a pathogen, adaptive immune cells
must orchestrate a persistent and coherent response from both the adaptive and innate
arms of the immune system, a task that requires the differentiation of CD4+ helper T (Th)
cells into one of several subsets. Notch signaling is critical for both of these development
processes, yet given the disparate demands of early and late T lineage development it is
unclear how such a basic signaling module can organize two distinct differentiation
mechanisms in the same lineage.

While Notch signaling is understood to instruct early T lineage development, there is little
consensus as to how the Notch pathway influences Th cell differentiation (Radtke et al.,
2013). Pioneering work with in vitro Th cell cultures yielded a paradigm in which the
quality and fidelity of Th cell differentiation was governed by a linear model: a lineage
inducing cytokine initiates a transcriptional program governed by a lineage defining
transcription factor, which in turn licenses that cell to produce a lineage defining cytokine
(O'Shea and Paul, 2010). While this highly stereotyped progression holds well in
traditional in vitro differentiation systems, activated CD4+ T cells are often exposed to a
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complex milieu of differentiating factors in vivo, each acting to push a Th cell down a
different lineage path. Within this framework, the need for molecules that function to
maintain signal within this noisy sea of differentiating cues becomes apparent. This
thesis contends that the Notch pathway functions as one such signal-integrating module
in the peripheral CD4+ compartment, distinct from its classical instructional role in early T
lineage development. The findings presented suggest that Notch signaling exerts distinct
mechanistic functions in early and late T lineage development and evinces a novel
signal integration model for Notch in hematopoiesis.

Overview of αβ-thymocyte development
Although many hematopoietic progenitor cells have the capacity to become T cells, only
a few migrate into the thymus (Bhandoola et al., 2007; Ng et al., 2009). Upon entry,
these thymic emigrants respond to their new environment by proliferating extensively
and initiating the T cell developmental program (Figure 1-1). The engagement of the T
cell lineage program involves the inactivation of stem cell and progenitor genes, the
activation of lineage specific factors, and the restriction of alternate fates (Rothenberg,

2012). Intimately intertwined with the transcriptional reprogramming of thymocytes, the
ongoing process of TCR rearrangement provides an additional level of regulatory
complexity to T cell development and can begin even before progenitors enter the
thymus (Allman et al., 2003; Igarashi et al., 2002).

In this manner, T cell development can be divided into multiple stages by the initiation of
the T cell transcriptional program and then several developmental checkpoints governed
by the ordered rearrangement of the TCR and the selection of a thymocyte’s antigen
2

receptor against self-peptides (Figure 1-1). These developmental stages are defined by
a set of surface markers that correlate with T cell maturation. The earliest populations of
thymocytes are defined by their lack of expression of the co-receptors CD4 and CD8,
and thus termed double negative (DN) cells. DN cells can be further subfractionated
based upon their expression of CD25, the IL-2 receptor α-chain, and CD44, a cell
adhesion receptor. The first cells to enter the thymus, DN1, are defined as CD25-CD44+
and progress to CD25+CD44+ DN2 cells, CD25+CD44- DN3 cells, and then CD25-CD44DN4 cells. From DN1 through DN3, thymocytes rearrange the TCRβ, in a recombination
activating gene (RAG) 1 and 2 dependent manner, and are held at a DN3 checkpoint
that ensures functional TCRβ expression, termed β-selection. Subsequent to the DN
stages of T cell development, thymocytes become double positive (DP) cells,
characterized by the surface expression of CD4 and CD8. At the DP stage, thymocytes
test

a

fully

rearranged

TCR

against

self-peptides

presented

on

the

major

histocompatibility complex (MHC), such that all thymocytes are capable of recognizing
self-MHC (positive selection), but do not activate upon engagement of a selfpeptide:MHC complex (negative selection). T cell development in the thymus ends when
thymocytes successfully undergo selection and become single positive (SP) for either
CD4 or CD8, as determined by the class of MHC that a thymocyte recognizes (MHC-I for
CD8+ SP cells and MHC-II for CD4+ SP cells).
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Figure 1-1: Stages of thymocyte development. Multipotent precursors are recruited to
the thymus in a CLL21 and CLL25 dependent manner and are initially maintained by IL7 and SCF survival signals, supplied by cortical thymic epithelial cells (cTECs). These
early precursors, DN1 cells, then initiate the T-lineage program upon Notch ligand
engagement and progress to the DN2 stage. At the DN3 stage, thymocytes begin to
express the pre-TCR complex, composed of pre-TCRα and TCRβ, and are licensed
undergo β-selection and proceed to the DN4 stage. Once the TCRα locus is functionally
rearranged and a mature TCR complex is expressed on the cell surface, DP thymocytes
are subjected to positive selection by interacting with MHC bearing cTECs at the corticomedulary junction. DP thymocytes then progress to either the CD4+ SP or CD8+ SP
stage, depending on the class of MHC their TCR recognizes. Thymocyte development is
completed after self-reactive SP thymocytes are eliminated by negative selection
through their recognitions of self-peptides presented by medullarly thymic epithelial
cells.
4

Building the T lineage identity
Multiple progenitor populations have been identified that can develop into T cells.
However, the resident bone marrow lymphoid primed multipotent progenitors (LMPP)
are understood to be the primary source of T cell precursors. Though they are enriched
for T cell potential, LMPP’s can also give rise to myeloid cells, NK cells, and B cells, but
not erythrocytes or megakaryoctyes (Yang et al., 2010). It is not until an LMPP
expresses the chemokine receptors CCR7 and CCR9 that they are able to migrate to the
thymus and begin T cell differentiation (Zlotoff et al., 2010).
Upon entry, the thymic epithelium provides these recent thymic emigrants (DN1 cells)
with a potent milieu of both soluble factors, such as interleukin 7 (IL-7) and stem cell
factor, as well as membrane bound ligands, the most critical of which are the Notch
ligands delta-like ligand 1 (Dll1) and Dll4, that support T cell development, proliferation,
and survival. Until a thymocyte successfully rearranges the TCR β-chain, these epithelial
derived signals sustain the T cell program during the earliest stages of development,
DN1 through DN3. Though the thymic environment strongly favors αβ T cell
development, other lineages can emerge from these pro-T cell populations and are
supported within the thymus. The potential to differentiate into these alternate lineages is
strongest at the DN1 stage and is almost completely lost by the DN3 stage (Rothenberg
et al., 2010).
This loss of multipotentiality is mirrored by a progressive termination of a stem cell-like
transcriptional identity and the emergence of a T cell specific transcriptional program,
composed of Notch1, TCF1, GATA3, and Bcl11b (Rothenberg, 2012). Global mapping
of histones and RNA-seq analysis of developing thymocytes has revealed that this
5

progressive loss of stem/progenitor-specific gene expression results from a variety of
histone transformations at multiple time points during development (David-Fung et al.,
2009; Tydell et al., 2007; Zhang et al., 2012). These data suggest that multiple
biochemically and temporally distinct mechanisms govern the transition from a stem-like
program to a T cell program, rather than a single switch (Zhang et al., 2012). Although
much of the stem cell gene expression program is turned off, it is important to note that
some genes sustain their expression throughout later stages of T cell development, such
as Myb and Ikaros. While these sustained genes may play important regulatory roles, it
has been suggested that they are unlikely to be rate-limiting factors for commitment
(Rothenberg, 2012).

Notch signaling
Notch receptors are a family of evolutionarily conserved type-I transmembrane
glycoproteins that play a critical role in large array of developmental processes, including
multiple stages of T cell development (Bailis et al., 2013; Fang et al., 2007; Han et al.,
2002; Maillard et al., 2004; Radtke et al., 1999). Mammals possess four different Notch
receptors (Notch1-4) that share homology with Drosophila Notch, and five Notch ligands.
The mammalian ligands Delta-like 1, 3, and 4 (Dll1, 3, 4) are homologous to the
Drosophila Delta, while Jagged1 and 2 are structurally similar to the Drosophila Serrate.
The extracellular portion of Notch is responsible for ligand interaction and is composed
of epidermal growth factor (EGF-like) repeats, LIN12 repeats (LNRs), and a membraneproximal heterodimerization domain (HD). In the absence of ligand, the LNR and the HD
domains constitute a negative regulatory region (NRR) that ensures Notch receptors
6

remain membrane-bound and transcriptionally inactive. In response to ligand, the Notch
intracellular domain (ICN) is released by proteolytic cleavage by gamma secretase and
directly mediates signal transduction. ICN consists of a RAM domain, 7 ankyrin-like
repeats (ANK), nuclear localization signal sequences, and a C-terminal PEST domain
that regulates protein stability (Figure 1-2).

While there are structural differences amongst the four Notch receptors, all are activated
in a ligand-dependent manner and converge on the same core transcriptional complex.
Upon Notch receptor-ligand interaction between two neighboring cells, a series of
proteolytic cleavage sites become exposed that lead to cleavage of an extracellular site
by ADAM family metalloproteases and subsequent cleavage of a transmembrane site by
a gamma-secretase complex. This proteolytic processing frees ICN from the membrane,
which then translocates to the nucleus and complexes with the transcription factor RBPJ
and MAML. MAML then recruits co-activators, such as p300 and PCAF, to form a large
multiprotein transcriptional activation complex. In this manner, Notch signaling results
from the conversion of a transmembrane receptor into a transcriptional activator,
allowing for rapid changes in target gene expression (Figure 1-3).

7

Figure 1-2: Structure of the mammalian Notch receptors and ligands. There are
four mammalian Notch receptors, Notch1-4, each of which can be activated by one of
four activating Notch ligands: Jagged1, Jagged2, Delta-like 1, and Delta-like 4. All four
Notch receptors contain an extracellular domain composed of a series of EGF-like
repeats followed by a LIN repeat containing region. The intracellular portion of the Notch
receptors consists of a RAM domain, a series of ankyrin-like repeats (ANK), and a PEST
domain that regulates protein stability. Notch1 and Notch2 additionally contain a
intracellular transcriptional activation domain (TAD), unlike Notch3 or Notch4.

8

Figure 1-3: Schematic of Notch signaling. Notch signaling is initiated when a Notch
receptor engages one of the four activating Notch ligands. This interaction exerts a
mechanical force on the receptor, exposing a series of proteolytic cleavage sites.
Metalloproteases and the γ-secretase complex then process the Notch receptor,
liberating the intracellular Notch domain (ICN). Once released from the membrane, ICN
is free to translocate to the nucleus where it interacts with its binding partners: RBPJ
and MAML. The assembly of the Notch transactivation complex recruits co-activators
(Co-A) that promote the transcription of Notch target genes.

9

Notch signaling and thymocyte development
Although Notch1, 2, and 3 are all expressed in developing thymocytes, only Notch1 is
both necessary and sufficient for T cell lineage commitment. Overexpression of the ICN1
fragment of Notch1 in bone marrow progenitors causes ectopic T cell development and
impairs B cell development, indicating a role for Notch in instructing the T rather than B
fate decision (Figure 1-4) (Pui et al., 1999). Consistent with gain-of-function data,
reciprocal loss-of-function experiments revealed that the inducible deletion of Notch1 or
RBPJ or expressing a GFP-tagged, dominant-negative form of MAML (DNMAML)
resulted in a severe block in T cell development at the DN stage and the accumulation of
thymic B cells (Han et al., 2002; Maillard et al., 2004; Radtke et al., 1999). Conditional
deletion models further mapped the stage-specific requirements for Notch signaling.
Deletion of a floxed RBPJ gene at the DN2 stage, using Lck-cre, resulted in a
developmental block at the DN3 stage, whereas use of a CD4-cre, which allows for
deletion between the DN3 and DN4 stages, did not alter T cell development (Tanigaki et
al., 2004). Moreover, the development of the DNMAML transgenic mouse provided the
ability to track Notch inhibition at the single cell level via the GFP tag on DNMAML.
Studies using these mice revealed that the developmental block observed in other lossof-function models occurred in DN3a cells at the β-selection checkpoint. Importantly,
when DN3 cells from Lck-cre x DNMAML mice are intrathymically injected into
recipients, DNMAML expressing thymocytes failed to give rise to appreciable numbers of
DP or SP cells, clearly illustrating an absolute requirement for Notch signaling in the DN
compartment (Maillard et al., 2006). Together, these data favor a model in which Notch
signaling is essential up until a functional TCRβ is rearranged, but that persistent Notch
signals are not essential thereafter. The findings discussed in this thesis will go on to
10

show that this transition from Notch-dependent to Notch-independent development at βselection is also accompanied by a switch in the oncogenic potential of the Notch
pathway as well as a shift in its activity as an lineage instructing factor to a signal
integrating factor that potentiates multiple fates.

Notch signaling and the pre-TCR
The timing of the transition from Notch-dependent to Notch-independent development
suggests cross-talk between pre-TCR and Notch signaling, and research has revealed
significant

interaction

between

these

two

signaling

pathways.

Chromatin

immunoprecipitation (ChIP) and reporter assays have shown that Notch signaling
governs pre-TCR signaling by regulating Ptcra gene expression, which encodes a
surrogate TCRα (pTa) that complexes with a functionally rearranged β-chain to facilitate
pre-TCR signaling (Bellavia et al., 2007; Reizis and Leder, 2002). In addition to directly
activating Ptcra expression, the Notch pathway also indirectly promotes Ptcra gene
expression. RBPJ shares a DNA binding motif with the transcription repressor Ikaros
and data suggests there is the potential for these two proteins to compete for binding
sites (Hsu et al., 1994; Ono et al., 1998). Signaling through Notch3 promotes the
expression of the RNA binding protein HuD, which results in enhanced generation of
Ikaros isoforms that lack the capacity to bind DNA, through alternative splicing. In turn,
these isoforms disrupt the activity of full-length Ikaros and mediate enhanced RBPJ
binding at pTa and increased Notch-dependent expression (Bellavia et al., 2007).
Finally, Notch signaling is also implicated in promoting rearrangement of the Tcrb loci,
suggesting that Notch might regulate pre-TCR signaling at the level of both pre-TCRα
and TCRβ expression (Ciofani et al., 2006; Wolfer et al., 2002).
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While Notch signaling is a key regulator of of the pre-TCR machinery, the resulting preTCR signals are essential for extinguishing Notch1 expression and mediating the
progression to Notch-independent development. From the DN1 stage up through the
DN3a stage of thymocyte development, Notch1 mRNA expression increases, and is
regulated both by Notch1 itself and the E-proteins E2A and HEB (Ikawa et al., 2006;
Yashiro-Ohtani et al., 2009). After β-selection, Notch1 expression sharply decreases in
DN3b cells and remains low for the remainder of thymic development (Taghon et al.,
2006; Yashiro-Ohtani et al., 2009). Accordingly, Notch1 expression is rapidly and
robustly downregulated upon PMA and ionmycin stimulation of Rag2-deficient DN3 cells,
demonstrating that pathways downstream of the pre-TCR are capable of directly
regulating Notch1 (Yashiro-Ohtani et al., 2009).
This interplay between pre-TCR signaling and Notch1 expression is mediated by crosstalk of these two pathways with E-proteins. While Notch signaling is the primary driver of
the T lineage program, E-proteins are essential for coordinating the kinetics of Notch
activity during thymocyte development. E2a deficiency results in decreased expression
of Notch1 and Notch3 in fetal thymocytes and causes a developmental block at the DN3
stage that can be rescued by overexpression of ICN1, placing Notch downstream of E2A
(Ikawa et al., 2006). Moreover, E2A activity mirrors that of Notch1. E2A remains active
until β-selection and pre-TCR signals promote the expression of the E-protein antagonist
Id3, which disrupts E2A DNA-binding in later stages of development (Bain et al., 2001;
Engel et al., 2001; Xi et al., 2006). Altogether, this creates a signal transduction circuit of
a feedforward loop involving E2A-driven Notch1 expression, followed by Notch1
autoregulation, which is then abolished by a negative feedback loop originating with pre-
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TCR signaling and terminating with Id3 antagonism of E2A and downregulation of
Notch1 expression (Yashiro-Ohtani et al., 2009).
In addition to the direct cross-talk between Notch and pre-TCR signaling, there is
significant interplay between the two pathways at the level of survival and proliferation
signals in DN3 cells. Both pathways display significant overlap with the AKT pathway
and AKT signals can bypass the requirement for both Notch and pre-TCR signaling at
the DN3 stage. Use of myristoylated AKT (myr-AKT), a membrane tethered and
constitutively active form of AKT, can partially bypass the requirement for Notch
signaling during β-selection (Ciofani and Zuniga-Pflucker, 2005). Furthermore, deletion
of the PI3K/AKT signaling antagonist, phosphatase and tensin homologue (PTEN),
permits the development of thymocytes from DN3 to DP cells, even in the absence of IL7 or pre-TCR signals (Hagenbeek et al., 2004). While AKT is downstream of pre-TCR
signaling, Notch signaling does not directly activate the AKT pathway. Notch has been
suggested to regulate AKT through multiple overlapping mechanisms. The canonical
Notch target Hes1 binds the Pten locus and negatively regulates Pten in both normal
and oncogenic T cell development (Palomero et al., 2007; Wong et al., 2012a). In a
separate arm of Notch-AKT cross-talk, components of the mammalian target of
rapamycin (mTOR) complex have been implicated as Notch pathway targets in the
context of T-ALL (Chan et al., 2007; Lee et al., 2012). Finally, Notch has also been found
to regulate the expression of receptors on thymocytes that engage the AKT pathway,
such as the insulin-like growth factor 1 receptor and the IL-7Ra (Gonzalez-Garcia et al.,
2009; Medyouf et al., 2011). Collectively these data support a model in which Notch and
pre-TCR signaling both provide critical inputs into the AKT pathway at the DN3 stage,
leading to a transition from a Notch-mediated to a TCR-driven survival program.
13

Although there is overlap between Notch and pre-TCR signaling, the two pathways are
not redundant in thymocyte development. Multiple groups have found that pre-TCR and
TCR signaling are incapable of compensating for a loss of Notch. In an in vitro T cell
differentiation system, retroviral expression of TCRβ or TCRαβ could not support T cell
development in the absence of Notch signals. Moreover, the same study found that antiCD3e treatment or expression TCRβ in conjunction with constitutively active Lck, Fyn,
Ras, or PKCα all failed to bypass the requirement for Notch, demonstrating that the
inability to overcome a lack of Notch signaling doesn’t stem from a quantitative
deficiency in pre-TCR signaling (Ciofani et al., 2004). Corroborating these in vitro
findings, the DN3 block observed in Lck-cre x DNMAML mice cannot be rescued by the
enforced expression of Tcrb or Tcra/b transgenes (Maillard et al., 2006). Conversely,
Notch signaling by itself is incapable of overcoming the loss of pre-TCR signaling. RAG2
deficient mice cannot generate the double-stranded breaks necessary for functional
TCRβ rearrangement and thus display a block at the β-selection checkpoint;
overexpression of ICN1 in these mice fails to restore development into the DP stage.
Similarly, overexpression of ICN1 in SLP76 deficient mice, an essential downstream
component of pre-TCR signaling, fails to drive the development of DP cells (Allman et
al., 2001).
While it remains unclear how these two pathways provide qualitatively distinct inputs into
T cell differentiation, recent work has begun to clarify this issue. Detailed analysis of
thymocyte expansion in the presence of cell cycle inhibitors has evinced an essential
role for proliferation in the DN to DP progression. In the absence of Notch signaling,
inducing proliferation by overexpression of either cell cycle machinery components or
the Notch target Myc was capable of partially restoring in vitro development up to the DP
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stage. In contrast, inducing proliferation by overexpressing cell cycle machinery was not
sufficient to rescue development in the absence of a pre-TCR, as seen in Rag2 deficient
thymocytes (Kreslavsky et al., 2012). Thus, the proliferative burst observed post-βselection is an essential downstream function of Notch during T cell development,
whereas the pre-TCR pathway provides distinct, cell-cycle-independent signals.
Altogether, these findings indicate that Notch and pre-TCR signaling each provide
essential and non-redundant inputs into thymocyte development.

Notch signaling and T-ALL
The robust pro-survival and proliferative signals provided by the Notch pathway during
normal thymopoiesis also make it a potent oncogene. Indeed, Notch was first discovered
through the analysis of T-ALLs with a (7;9) translocation that resulted in the fusion of
NOTCH1 on chromosome 9 to TCRB enhancer/promoter elements and the aberrant
expression of a constitutively active, truncated nuclear Notch1 (Ellisen et al., 1991).
When ICN1 is expressed in murine bone marrow progenitors, a rapid onset T-ALL
emerges, demonstrating that Notch activation is sufficient for transformation (Figure 1-4)
(Pear et al., 1996).

While originally identified in tumors containing a TCRB translocation, this mutation was
later found to be rare. Instead, the predominant NOTCH1 gain of function mutations,
which are found in over 60% of human T-ALLs, occur via point and truncation mutations
to the NOTCH1 gene itself (Weng et al., 2004). The majority of NOTCH1 mutations arise
from point mutations to the NRR, which either destabilize the extracellular domain and
permits ligand-independent cleavage of Notch1 and release of the ICN signaling peptide,
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or they destroy the PEST domain, which prolongs the half-life of nuclear NOTCH1
(Weng et al., 2004). Both classes of mutations allow cells to both increase the level of
Notch signal received and sustain Notch signaling in environments that no longer
support it. Although this increased “portability” of Notch signaling may the play a part in
allowing transformed cells to escape the thymus, the dose of Notch signaling is a critical
determinant of whether Notch acts as an oncogene or an effector of T cell development.
Weak activating mutations to the NRR or PEST domain are sufficient to drive ectopic T
cell development in transduced bone marrow cells and suppress B and myeloid
differentiation, but fail to give rise to leukemia in the absence of additional genetic
lesions. However, when multiple activating mutations to Notch are present or when ICN1
is expressed, the resulting signals promote both ectopic T cell development and
leukemia (Chiang et al., 2008). Thus, normal T cell development must walk a tenuous
line between the ability of Notch1 to initiate and drive the T cell program and the capacity
of Notch to act as a potent oncogene.

The oncogenic potential of Notch signaling likely stems from its positioning as a key
regulator of multiple pro-survival and pro-proliferative pathways. ChIP-on-chip profiling
after Notch inhibition in gamma-secretase inhibitor (GSI) treated T-ALL cell lines
revealed that more than 40% of Notch-responsive loci were effectors of cell metabolism
and protein biosynthesis (Palomero et al., 2006). Among these genes, c-Myc has been
identified as a critical Notch target in T-ALL (Palomero et al., 2006; Sharma et al., 2006;
Weng et al., 2006). Expression of c-Myc rescues T-ALL cell lines from Notch withdrawal
and c-Myc inhibitors block the ability of ICN1 to rescue T-ALL cell lines from GSI
treatment, demonstrating that c-Myc is both necessary and sufficient for Notch1’s
leukemogenic functions (Palomero et al., 2006; Sharma et al., 2006; Weng et al., 2006).
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In addition to c-Myc, Notch signaling has also been suggested to regulate the NF-κB and
AKT pathways. Ectopic expression of ICN1 in bone marrow progenitors promotes the
nuclear localization of NF-κB, the expression of NF-κB components, and the expression
of NF-κB target genes. Although inhibition of NF-κB impairs the growth of Notch1dependent human T-ALL cell lines, NF-κB is not sufficient to drive T-ALL (Vilimas et al.,
2007). Given that NF-κB signaling is necessary but not sufficient for T-ALL, NF-κB may
act in collaboration with Notch1 to promote c-Myc expression, as studies have identified
NF-κB binding sites in the Myc promoter (Park and Wei, 2003). In parallel to its affects
on NF-κB, Notch signaling has also been implicated in regulating the AKT pathway in
cancer. The Notch-Hes1-PTEN axis seen during thymocyte development is an important
mediator of Notch driven T-ALL. Loss of PTEN is a frequent occurrence in GSI-resistant
T-ALLs and is sufficient to rescue the survival and proliferation defects observed in GSI
treated, Notch-dependent T-ALL cell lines, indicating AKT is an important downstream
effector of Notch in T-ALL (Palomero et al., 2007). Accordingly, AKT signaling has been
found to be a critical downstream mediator of Notch1-driven glycolysis (Landor et al.,
2011). Moreover, multiple reports have linked Notch signaling to the AKT pathway
member mTOR. Loss of Rictor, a component of mTORC2, significantly increases
median survival and reduces leukemic cell organ infiltration in a murine model of Notch1induced T-ALL (Lee et al., 2012). Corroborating this finding, GSI treatment or expression
of DNMAML in T-ALL cell lines results in the inhibition of multiple components of mTOR
signaling that could be rescued by expression of ICN1 (Chan et al., 2007). Altogether
these data indicate that while c-Myc is the primary mediator of Notch-driven T-ALL,
Notch signaling regulates multiple pathways with known oncogenic roles and likely
promotes transformation by the overlapping pro-survival and pro-proliferative inputs from
these signals. Chapter 3 will review data illustrating that the oncogenic activity of Notch
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is lost after β-selection, opening the way for future studies to identify the molecular and
cellular contexts in which Notch can transform cells.
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Figure 1-4: Notch signaling and T lineage development. Notch signaling instructs T
cell development in LMPP’s at the expense of B cell differentiation. The pathway
remains active from the DN1 through the DN3 stage of thymocyte development, where it
is a critical regulator of proliferation and cell survival. Hyper-activation of Notch signaling
during this period results in the potent induction of T-ALL. Notch signaling is
extinguished once a thymocyte successfully passes through the β-selection checkpoint
and the remainder of thymic development is understood to be Notch-independent. When
a mature, naïve CD4+ T cell enters the periphery and becomes activated, Notch
signaling is reinitiated and understood to play an important role in subsequent Th cell
differentiation decisions; however it remains unclear how or whether Notch instructs the
fate of these various subsets.
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Peripheral CD4+ T cell differentiation
The Th1-Th2 paradigm and the linear instruction model
Though CD4+ T cell diversity has long been appreciated, our ability to delineate the
discrete boundaries that define individual Th cell populations has waxed and waned as
our understanding of the complex relationship between these subsets has evolved. Initial
efforts to classify Th cell subsets ranged from the use of cell surface antigens (Arthur
and Mason, 1986; Bottomly, 1988; Morimoto et al., 1985a; Morimoto et al., 1985b), to
designations based on short- and long-term survival post-thymectomy (Kappler et al.,
1974), and even classifying Th cells based on the use of antigen recognition versus B
cell idiotype recognition (Bottomly and Mosier, 1979; Janeway et al., 1977). While these
methods were effective in fractionating the CD4+ T cell compartment, they did not yield
consistent functional immune correlates (Mosmann and Coffman, 1989).

Following the establishment of the first functional T cell hybridoma lines and the
relentless efforts to identify and characterize the growing world of “lymphokines,” Tim
Mossman and Richard Coffman were equipped with the tools necessary to establish the
modern Th cell paradigm (Kontiainen et al., 1978; Mosmann and Coffman, 1989). The
observation that T cell hybridoma lines separated into two distinct groups based on
cytokine production and that this pattern of cytokine production could predict the mode of
B cell help given revolutionized our understanding of host immunity (Mosmann et al.,
1986). Moreover, the findings that these disparate Th cell cytokine phenotypes were
stable over periods as long as 18 months and failed to interconvert provided compelling
evidence that these populations were distinct lineages (Mosmann and Coffman, 1989).
Subsequent studies demonstrating that this method of Th cell fractionation was sufficient
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to explain whether certain inbred mouse strains were susceptible to specific classes of
pathogens, based on the cytokine bias of Th cell from these mice, illustrated that
cytokines and Th cell subtype – not just antigen/MHC specificity – were critical
determinants of pathogen-specific immune responses (Else and Grencis, 1991; Heinzel
et al., 1989; Locksley et al., 1987; Sadick et al., 1987; Scott et al., 1988).

Once the precursor-product relationship for both Th1 and Th2 cells was mapped back to
a common progenitor – the thymectomy-sensitive, naïve T cell – efforts became focused
on understanding how a bifurcation in fate choice could arise in a developmentally
mature cell type (Seder and Paul, 1994). It was appreciated early that exogenous factors
played a key role in differentiation. The signature cytokines of each Th cell subtype were
found to act in an autocrine manner to reinforce their corresponding program and inhibit
the adoption of the alternate phenotype (Fernandez-Botran et al., 1988; Gajewski and
Fitch, 1988). Furthermore, the observation that IL-12 was necessary and sufficient to
induce Th1 differentiation via STAT4 (Gazzinelli et al., 1993; Hsieh et al., 1993; Kaplan
et al., 1996b; Thierfelder et al., 1996) and that IL-4 via STAT6 was necessary and
sufficient for Th2 differentiation (Betz and Fox, 1990; Hou et al., 1994; Kaplan et al.,
1996a; Le Gros et al., 1990; Swain et al., 1990) suggested that these two population
differentiated in response to unique signaling modules, despite shared pathways
downstream of the TCR and co-stimulation. Finally, the discovery of Tbet and Gata3 as
factors that were not only obligate for Th1 and Th2 differentiation, respectively, but could
impose Th1 or Th2 phenotypes on already differentiated cells cemented the notion that
discrete, mutually-exclusive Th cell subsets existed and solidified a linear instruction
model of Th cell differentiation that has come to dominate the field (Figure 1-5) (Szabo et
al., 2000; Zheng and Flavell, 1997).
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Many aspects of this model have been repeatedly supported by findings in the literature,
demonstrating its predictive utility, particularly in vitro and within the bi-polar Th1-Th2
paradigm. The linear instruction hypothesis contends that differentiated cells will have
distinct functional programs, governed by unique transcriptional networks downstream of
unique exogenous factors that are self-reinforcing and antagonistic to alternate fates.
Indeed, cytokine production by Th cells is often dominated by either IFNγ or IL-4 in a
large number of classically used infection models (Else and Grencis, 1991; Heinzel et
al., 1989; Locksley et al., 1987; Sadick et al., 1987; Scott et al., 1988). Moreover, the
ability of Th cells to provide host protection in these models requires animals to have the
capacity to express the appropriate fate-specifying cytokines or cytokine receptors, the
signal transducers that are downstream of those cytokine receptors, and a discrete and
specific network of transcription factors regulated by those signal transducers (Altare et
al., 1998; Mattner et al., 1996; Rosas et al., 2006; Stamm et al., 1999; Urban et al.,
1998). Not only does each Th cell subset require these transcription factor networks, but
enforced expression of one network has been shown to destabilize the activity of others
(Szabo et al., 2000; Zheng and Flavell, 1997). Altogether, the strength of the linear
instruction hypothesis has led to its use as a predictive mechanistic model for
experimental findings for nearly a quarter century.
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Figure 1-5: The linear instruction model of Th cell differentiation. Naïve CD4+ T
cells differentiate in response to unique cytokine mixtures soon after activation.
Cytokines stimulate the activation of signal transducers that in turn promote the
expression of lineage defining “master regulator” transcription factors. The master
regulators imprint lineage identity, as defined by the production of a signature cytokine,
and restrict potential for alternate Th cell fates. STAT4 acts downstream of IL-12 to
induce Tbet expression and impose the Th1 identity. IL-4 signaling activates STAT6,
resulting in Gata3 expression and Th2 differentiation. A combination of the
immunoregualtory factor TGFβ and the immunoinflammatory cytokine IL-6 results in
STAT3-dependent Rorγt expression. Finally, the Treg cell identity is imprinted by the
expression of Foxp3, which is induced by TGFβ plus IL-2 and requires STAT5.
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More lineages, more problems: the linear instruction model challenged
Despite the durability of this hypothesis, many experimental observations are largely
inconsistent with its implicit predictions. Researchers have long been aware that many
human Th cell populations fail to fall within these mutually exclusive bins, with the
exception of instances of severe inflammation (Bucy et al., 1994; Kelso, 1995; Maggi et
al., 1988; Romagnani, 1991). Even in the in vitro systems employed by Mosmann and
Coffman, cells failed to show cytokine production or transcription patterns on a single
cell level that were consistent with single, dominant transcriptional programs (Bucy et al.,
1994). More recently, the identification of IL-17A producing Th17 cells (defined by Rorγt
and induced in the presence of TGFβ plus IL-6) and TGFβ producing Treg cells (defined
by Foxp3 and induced in the presence of TGFβ plus IL-2) has presented the model’s
greatest challenge (Bettelli et al., 2006; Brunkow et al., 2001; Chatila et al., 2000;
Fontenot et al., 2003; Ivanov et al., 2006). Although researchers have shown that these
populations can be generated in vitro based on first principles of the linear instruction
hypothesis, the identification of Th17 and Treg cells has called several key aspects of
this model into question.

An essential component of the linear instruction hypothesis is that each Th cell identity is
defined by the expression of unique cytokine profiles and the identity of each subset is
actively maintained by the expression of a single “master regulator.” Initial findings from
Th17 and Treg studies were consistent with these axioms, however the existence of Th
cell populations that produce multiple lineage defining cytokines and transcription factors
is now widely appreciated. Th17 cells have been shown not only to have the capacity to
produce both IL-17A and IFNγ concurrently, but also the ability to lose IL-17A expression
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and solely produce IFNγ (Algood et al., 2007; Bending et al., 2009; Chen et al., 2007;
Lee et al., 2009; Shi et al., 2008). Consistent with cytokine production data, Th17 cells
have also been found to simultaneously express Tbet and Rorγt (Annunziato et al.,
2007; Shi et al., 2008). In addition to the mixed Th cell profile observed in Th17 cells,
Treg cells have also been found to exhibit features of Th cell duality. Given their shared
requirement for TGFβ in differentiation, it is not surprising that Th cells can co-express
Foxp3 and Rorγt and that Foxp3+ cells can produce IL-17A (Xu et al., 2007; Yang et al.,
2008). Perhaps more unanticipated, Tregs are now known to have the potential to
express the Th1 and Th2 “master regulators,” Tbet and Gata3. Foxp3+ cells have been
found to co-express Tbet and IFNγ and these factors are understood play an important
role in Treg localization and repressor function during type-1 inflammatory responses
(Koch et al., 2009; Oldenhove et al., 2009; Sawitzki et al., 2005; Stock et al., 2004).
Similarly, not only can Tregs co-express Foxp3 and Gata3, but Gata3 expression in
Tregs has also been found to play an essential role in Treg biology and may even act to
limit inflammatory Th cell differentiation (Rudra et al., 2012; Wang et al., 2011; Wohlfert
et al., 2011). Further complicating the role of Gata3 as the “master regulator” of Th2
differentiation, Gata3 expression is also required for the differentiation of IL-9 producing
Th9 cells (Dardalhon et al., 2008; Veldhoen et al., 2008). While IL-9 secreting cells can
produce IL-4 like Th2 cells, Gata3+IL-4- Th9 cells can exist as a population independent
of Th2 cells and there are even IL-17A+ cells that have the capacity to produce IL-9
(Elyaman et al., 2009; Licona-Limon et al., 2013). Altogether, these data are
fundamentally incompatible with the linear instruction hypothesis and are more indicative
of a continuum of states and/or overlapping functional programs.
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These findings not only suggest that Th cells are capable of simultaneously supporting
multiple programs to generate nuanced responses, but also illustrate a second
irreconcilable axiom of the linear instruction hypothesis: that the unique cytokine
signatures of Th cells are representative of discrete lineages. By definition, a cell lineage
represents a distinct developmental progression resulting in a stable functional grouping
of cells. The extent to which functional groups can interconvert dictates whether multiple
cell populations represent true lineages (i.e. T versus B lineage cells) or whether they
instead represent modular functional programs within a single lineage (i.e. IgE versus
IgG producing B cells). As described above, Th cells have the capacity to change
cytokine production and transcriptional network profiles. The fact that this had only been
observed with regard to the Th17 and Treg phenotypes had previously been cited as
evidence to argue that Th1 and Th2 cells did in fact represent distinct cell lineages (Zhou
et al., 2009b). However, recent work demonstrates that interferons and IL-12 can
reprogram Th2 cells into a hybrid Gata3+Tbet+ state during viral infection, evincing that
these two Th cell types are in fact not stable, mutually exclusive lineages, but rather are
reprogrammable, semi-stable functional modules (Hegazy et al., 2010). Importantly, this
has not only been shown functionally but also at the level of epigenetic regulation. ChIPseq analysis of Th cell populations has revealed that, rather than shutting down
transcriptional programs for alternate fates as has been observed in similar analyses of
related lineages, differentiated Th cells maintain signature genes for alternate programs
in a poised chromatin conformation (Cedar and Bergman, 2011; Wei et al., 2009). Thus
Th cell type flexibility appears to be a normal feature of CD4+ T cell activation.

In light of the mounting evidence that Th cell differentiation is unlikely to operate under
the linear instruction model, it is worthwhile reconsidering the Th subtype-specific
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instructional roles that have been ascribed to a wide variety of exogenous cues that are
received by activated CD4+ T cells. Activated CD4+ T cells integrate a multitude of
external signals in addition to cytokines, including signals derived from the TCR and costimulatory molecules. Although originally described as instructive, these molecules
have all been found to play a role in the differentiation of multiple Th cell subsets.

Antigen dose and altered peptide ligand studies have been used to argue that TCR
signal strength instructs Th1 or Th2 differentiation: with high levels of TCR stimulation
suggested to instruct Th1 differentiation and weak TCR stimulation suggested to instruct
Th2 differentiation (Constant and Bottomly, 1997; Zhu et al., 2010). In stark contrast to
these peptide-based studies, in vivo infection models have shown that high levels of
infection correlate with higher levels of Th2 cytokine production, whereas lower levels of
infection result in increased Th1 cytokine production, with pathogens ranging from
Leishmania major to Trichuris muris giving the same result (Bancroft et al., 1994;
Bretscher et al., 1992; Nicholson et al., 1995; Sarzotti et al., 1996). While there are
obviously many confounding factors that affect our ability to interpret these in vivo
infection studies, it is clear that antigen dose itself is neither necessary nor sufficient to
instruct Th cell type choice, in contrast to cytokines in these models. Moreover, O’Garra
and colleagues observed that both very high and low doses of ovalbumin peptide
promote Th2 differentiation, suggesting that the influence of TCR signaling on Th cell
differentiation is not simply a matter of signal strength (Hosken et al., 1995). Finally, the
Th2-biasing activity of altered peptide ligands that diminish TCR signal strength is highly
dependent on the cytokine environment, with higher doses IL-2 being sufficient to
override these effects (Tao et al., 1997). Hence, while TCR signaling can influence both
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Th1 and Th2 differentiation under certain conditions, it does not display activities
consistent with an instructional pathway.

Like TCR signaling, the linear instruction hypothesis has been applied to the role of costimulatory molecules in Th cell differentiation. The B7 family of co-stimulatory molecules
– consisting of CD28, CTLA4, and ICOS – play an essential role in T cell activation and
have also been argued to instruct Th cell differentiation (Constant and Bottomly, 1997;
Zhu et al., 2010). Although multiple studies initially implicated CD28 and CTLA4 as
instructive signals, these molecules were found to play unbiased roles in Th cell
differentiation and instead are critical tuners of T cell activation (Constant and Bottomly,
1997; Zhu et al., 2010). ICOS has similarly been suggested to instruct Th2
differentiation, with ICOS deficient mice reported to display severely impaired IL-4
production (Dong et al., 2001). However, subsequent studies have illustrated a complex
role for ICOS in Th cell biology. Inhibition of ICOS signaling has been found to both
positively and negatively regulate IL-4 and IFNγ production in in vivo models as well as
promote or protect against the Th17-mediated disease model experimental autoimmune
encephalomyelitis, depending on the timing of ICOS inhibition (Harada et al., 2003;
Rottman et al., 2001; Sporici et al., 2001). Moreover, ICOS signaling has also been
shown to be critical in Treg differentiation and/or function, where it has even been found
to be necessary for limiting Th2 responses (Akbari et al., 2002; Herman et al., 2004).
Collectively, these findings indicate that, while both TCR and co-stimulation are critical
inputs that can influence Th cell differentiation, they do not behave instructionally and
their diverse activities in multiple Th cell populations highlights the existence of a large,
shared signaling network amongst the Th cell subsets.
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As discussed above, outside of the role that highly defined mixtures of cytokines play in
Th cell differentiation in vitro, the vast majority of evidence suggests that Th cell
differentiation operates as a series of overlapping functional modules coordinated by a
large, shared network of signaling pathways that are integrated to provide semi-stable
effector states. Within this framework, the need for molecules that help integrate these
inputs into coherent outputs becomes just as great as the need for cytokines in enforcing
specific functional outcomes. Although initial efforts were spent attempting to fit the
Notch signaling pathway into the linear instruction model, this thesis contends that the
Notch pathway instead acts as an unbiased integrator of environmental differentiation
cues.

Notch signaling in peripheral CD4+ T cell differentiation
Notch as an instructor of Th1 versus Th2 cell differentiation
Given the Notch pathway’s unequivocal instructional role in T lineage commitment from
normal hematopoietic progenitors and in launching the T-ALL program from
dysregulated precursors, it is not surprising that this classical instructional paradigm was
also applied to its role in Th cell differentiation. With only Th1 and Th2 cells appreciated
at the time, Amsen and colleagues hypothesized that Notch signaling instructed this
process much like it did in other bipotential fate decisions. They went on to find that
while Notch pathway did display some characteristics of an instructional pathway, the
outcome of Notch signaling depended on the type of presenting Notch ligand. Delta-like
ligands expressed on MHC-bearing fibroblasts were shown to instruct Th1 differentiation
and limit Th2 differentiation, while Jagged ligands were found to instruct Th2
differentiation. Intriguingly, they also observed that LPS treatment could induce Notch
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ligand expression on dendritic cells (DCs) in a TLR4 dependent manner, and that
Jagged and Delta-like ligands could each be selectively expressed by stimulation with
unique stimuli, fitting with a prevailing model that the caliber of Th cell responses is
patterned by the activating stimuli antigen presenting cells receive. Despite these
findings, RBPJ deficiency only affected the ability of LPS treated DC’s to promote IL-4
production, even though this stimulus induced the expression of both Delta-like and
Jagged ligands. Reciprocally, expression of ICN1 in T cells only resulted in increased
Th2 differentiation (Amsen et al., 2004). Further complicating these findings, another
study using a similar Notch ligand expression system found no instructive capacity for
either Jagged or Delta-like ligands. Instead, they argued for a model in which Notch
behaves selectively to promote Th1 or Th2 differentiation, but in a manner entirely
dictated by upstream cytokine signaling (Ong et al., 2008). There is now also evidence
that Delta-like ligands are key regulators of Th2 responses in vivo and that Jagged
ligands can promote Th1 differentiation (Jang et al., 2010; Le Friec et al., 2012;
Mukherjee et al., 2014). Nevertheless, this seminal study established the ligand
instruction model, which would become the prevailing hypothesis for the complex role
Notch signaling plays during Th cell differentiation.
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Figure 1-6: The Notch ligand instruction model. Notch ligands have been proposed
to differentially instruct either Th1 or Th2 differentiation. In this model, Delta-like ligands
are thought to instruct Th1 differentiation by promoting the transcription of Tbx21 and
Ifng and by inhibiting Th2 differentiation downstream of the IL-4R, though the
transcriptional and inhibitory activity of the Notch pathway in this setting has not formally
been shown. Similarly, Jagged ligands are thought to instruct Th2 differentiation by
directly promoting the transcription of Il4 and the transcription of Gata3 from exon 1-a.
However, the Gata3-1a transcript represents a minor fraction of the total Gata3 mRNA,
with the Gata3-1b isoform being the dominant transcript, regulated downstream of IL-4R
signaling.
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Subsequent studies similarly argued for an instructional model, however they disagreed
with regard to which Th cell subset Notch signaling promoted. Oral administration of γsecretase inhibitors (GSI) or pre-treatment of T cells with GSI was reported to severely
inhibit IFNγ production by Th1 differentiated cells, while having no effect on IL-4
production under both Th2 and non-polarizing conditions. The same study also found
that GSI treatment inhibited Tbx21 (Tbet) transcription, but not Gata3, and expression of
ICN1 could enhance IFNγ production and Tbx21 transcription, even in Th2 differentiated
cells, via binding to the Tbx21 promoter (Minter et al., 2005). In addition to reported roles
for Notch1 in promoting Th1 differentiation, Notch3 has also been suggested to instruct
the development of this Th subset. Exogenous expression of ICN3 in T cells resulted in
enhanced Th1 differentiation at the expense of Th2 differentiation, and the same effect
was observed upon treating mice or T cells with an activating Dll1-Fc fusion protein
(Maekawa et al., 2003). Further highlighting a role for Notch signaling in Th1
differentiation, LPS treated CD8- DC’s have been shown to promote Th1 differentiation
independent of IL-12 production. This phenomena has been suggested to be due to
increased expression of Dll4 on CD8- DC’s that in turn results in Dll4-dependent Th1
differentiation, however the requirement for Notch signaling in the receiving T cells was
never tested (Skokos and Nussenzweig, 2007).

In spite of evidence supporting Notch as a selective instructor of Th1 differentiation,
multiple in vitro and in vivo loss-of-function studies have contended the contrary. In
addition to data from RBPJ deficient T cells discussed above, work using CD4-cre x
DNMAMLFL/FL T cells also found that Th2 differentiation was severely impaired when
Notch signaling was inhibited, while Th1 differentiation remained intact. Moreover, these
mice were resistant to L. major infection, a Th1-dependent model, but susceptible to T.
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muris infection, which requires a Th2-dependent immune response for protection (Tu et
al., 2005). Corroborating these findings, CD4-cre x RBPJFL/FL mice exhibit a significantly
impaired Th2 response and an enhanced Th1 response following immunization and
restimulation with Schistosoma mansoni egg extract and have also been found to be
resistant to L. major infection (Amsen et al., 2007; Auderset et al., 2012). Not only has
loss of Notch signaling been found to impair Th2 differentiation, but expression of ICN1,
and to a lesser extent ICN2-4, robustly and selectively promotes Th2 differentiation in
vitro (Amsen et al., 2007; Fang et al., 2007).

At the transcriptional level, Notch is thought to mediate this instructive capacity by
directly regulating the Il4 and Gata3 loci. Notch1 binds to and directly regulates Il4, as
seen in ChIP analysis and luciferase assays (Amsen et al., 2004; Fang et al., 2007).
This activity is dependent on the 3’ Il4 enhancer, HS5: when Notch signaling is enforced
in transgenic T cells bearing an Il4 minilocus, transcription from the minilocus is only
enhanced when constructs contain the HS5 (Amsen et al., 2007). Notch regulation of Il4
also requires Gata3 activity, but can occur in the absence of STAT6. Expression of ICN1
in Gata3-deficient T cells or in the presence of a dominant-negative Gata3 failed to
promote IL-4 protein expression (Amsen et al., 2007; Fang et al., 2007). Moreover, while
expression of ICN1 alone had a minimal capacity to enhance IL-4 production in Th1
cultures, co-expression of Gata3 and ICN1 synergistically promoted IL-4 production in
Th1 cells, in a STAT6-independent fashion (Fang et al., 2007). While these findings
established Notch as a regulator of the Th2-defining cytokine, they also raise questions
over the Th2 instructing capacity of the Notch pathway. Although ICN1 can induce IL-4
expression in activated T cells and even reprogram Th1 cells, Notch signaling itself was
not sufficient for either of these functions and required the potent stabilizer of Th2
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identity, Gata3. In fact, Notch potentiates Th1 differentiation in Gata3-/- T cells (Amsen et
al., 2007). These data may instead suggest that Notch lacks any instructional activity
alone and rather cooperates with other regulators of Th cell programming.

Not only has Notch been shown to regulate Il4 in cooperation with Gata3, but it has also
been found to directly regulate Gata3 itself. Gata3 can be expressed as two transcripts
through two different variants of exon 1: Gata3-1a and Gata3-1b (Asnagli et al., 2002).
As shown by both ChIP and EMSA, the Notch transcriptional activation complex can
associate with both exons 1a and 1b. In addition, GSI treatment inhibits the
accumulation of Notch at both regions, indicating that Notch has the potential to
dynamically modulate Gata3 expression through both transcripts (Amsen et al., 2007;
Fang et al., 2007). Although expression of DNMAML decreased transcription at both
sites after seven days of culture, expression of ICN1 was sufficient to potently drive
Gata3-1a transcription after only 36 hours and failed to activate transcription at Gata31b, suggesting that Notch only regulates expression of transcripts initiated at exon 1a
(Fang et al., 2007). Despite compelling data indicating that the Notch pathway can
directly regulate Gata3 expression, it’s inability to drive expression at Gata3-1b does not
fit with an instructional role for Notch. While both transcripts are expressed in Th2 cells,
Gata3-1b is expressed within the first 24 hours of activation, whereas expression from
Gata3-1a doesn’t begin until day 3 post activation (Asnagli et al., 2002; Yu et al., 2009).
Moreover, Gata3-1b transcripts are much more abundant that the Gata3-1a variant (Yu
et al., 2009). Thus, although Notch can regulate Gata3-1a, the kinetics and magnitude of
expression are incompatible with an instructive role for Notch in Th2 differentiation, via
Gata3. Chapter 2 will discuss data suggesting that Notch does not instruct Th cell
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differentiation, but instead acts to simultaneously promote the differentiation of Th1, Th2,
and Th17 cells by sensitizing cells to exogenous differentiating cues.

Notch and non-classical Th cell subsets
While studies conflicted over whether Notch instructed Th1 versus Th2 differentiation,
the ligand instruction model was made even more tenuous by additional reports
implicating Notch in other Th cell populations. Suggesting a role for Notch in Th17
biology, recombinant-Dll4 stimulation can promote Th17 differentiation in vitro and TLR
stimulated APCs can enhance Th17 differentiation in a Dll4 and Notch dependent
manner. This effect was suggested to be mediated by Enhanced STAT3 signaling as
well as by the ability of the Notch transactivation complex to bind to the Rorc (Rorγt)
promoter (Mukherjee et al., 2009). A second corroborating study similarly showed that
siRNA knockdown of Notch1 or GSI treatment of human and mouse T cells inhibited in
vitro Th17 differentiation. This study not only confirmed Notch binding to Rorc by ChIP,
but also identified Il17a as a probable direct target (Keerthivasan et al., 2011). Findings
from both these studies indicate that Notch signaling regulates Th cell differentiation
beyond the Th1/Th2 paradigm and that Dll4 can promote the differentiation of non-Th1
subsets, which is not consistent with predictions from the ligand instruction model.

In addition to Th17 differentiation, Notch signaling has now been suggested to regulate
the putative Th cell subsets Th9 and T follicular helper (Tfh) cells (defined by Bcl6
expression and IL-21 production) (Crotty, 2011). CD4-cre x Notch1FL/FLNotch2FL/FL mice
display impaired IL-9 secretion under both Th9 and Th17 conditions. Conversely,
Jagged ligand stimulation or ICN1 expression results in enhanced IL-9 production. This
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effect on IL-9 is direct: Notch binds to the Il9 promoter, where it synergizes with Smad3
to induce transcription, as seen in ChIP and luciferase assays (Elyaman et al., 2012).
While the data supporting a role for Notch in Th9 biology is compelling, it is unclear the
extent to which Notch is involved in the differentiation or the function of this subset.
Moreover, the extent to which Th9 cells represents a bona fide Th cell subset or IL-9
production is a functional module that can be overlaid on top of Th2 and Th17
differentiation remains undetermined (Murphy and Stockinger, 2010).

Like Th9 cells, it is unclear if Tfh cells should be characterized as a distinct Th cell
subset or as a program parcel that can further specialize Th1 and Th2 cells (Murphy and
Stockinger, 2010); nonetheless recent work suggests that Notch signaling may be
involved in Tfh biology. CD4-cre x Notch1FL/FLNotch2FL/FL display severely impaired Tfh
responses after immunization with peptide, L. mexicana, or S. mansoni eggs. Mixed
bone marrow chimeras similarly displayed reduced Tfh differentiation in immunization
models, however the presence of WT cells partially rescued this defect, suggesting this
is not entirely a cell autonomous phenotype. The finding that Notch signaling modulates
the balance of Bcl6 and Blimp1 (a transcription factor known to antagonize Bcl6 activity)
in activated T cells offers one potential explanation for this observation, but this was
shown to be an indirect effect. Further complicating this study, CD4-cre x
Notch1FL/FLNotch2FL/FL mice have compromised germinal center architecture and cell
number following immunization or infection and are known to have defects in IL-4
production (Auderset et al., 2013). Given Tfh cells require normal germinal center
function to properly differentiate, it is unclear whether these Tfh defects are caused by or
are responsible for complications in germinal center formation (Crotty, 2011). Until the
relationship of Tfh cells to the other known Th cell subsets is established, it will be
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difficult to resolve whether these findings truly indicate a role for Notch in Tfh
differentiation or if they instead result from impaired Th1 or Th2 differentiation due to
loss of Notch signaling.

While the role Notch signaling plays in inflammatory Th cell differentiation is disputed,
there is no greater clarity as to how Notch influences Treg biology. Both Notch1 and
Notch 3 have been suggested to promote Treg differentiation. Lck-cre x ICN3FL/FL mice
display a nearly twenty-fold expansion of CD25+Foxp3- cells, but also exhibit a roughly
three-fold expansion of CD25+Foxp3+ cells. Moreover, these cells demonstrate elevated
suppressor function. This expanded Treg population is lost when ICN3-transgenic mice
are crossed to Ptcra-/- mice, indicating that these cells are likely naturally occurring
Tregs. It is worthwhile noting that these mice also develop T-ALL, making it difficult to
determine whether these effects are secondary to additional complications in these mice
(Anastasi et al., 2003; Campese et al., 2009). A second study found that GSI pretreatment of T cells or expression of an antisense Notch1 transgene resulted in
decreased Treg differentiation in vitro. However, cleaved Notch1 protein was still present
in significant quantities upon GSI treatment and Notch1 antisense expression,
suggesting that the phenotypes observed cannot solely be explained by an absence of
Notch signaling. The same study also found that Notch1 can bind to the Foxp3 promoter
and GSI treatment depleted Notch1 from this region, however histone acetylation at both
the Foxp3 promoter and an enhancer was unaffected and the consequence of this
binding on transcription was never evaluated (Samon et al., 2008). In contrast to these
two reports, multiple in vivo studies have found that inhibition of Notch signaling results
in increased Treg differentiation. In models of graft-versus-host disease (GvHD) and
experimental autoimmune encephalomyelitis (EAE), inhibition of Notch signaling
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ameliorates disease and results in decreased inflammatory T cell differentiation coupled
with enhanced Treg differentiation (Bassil et al., 2011; Sandy et al., 2013; Tran et al.,
2013; Zhang et al., 2011). Not only do this disease models highlight a role for Notch in
antagonizing Treg differentiation, but the observation that there are no steady-state
developmental or inflammatory defects in mice with a conditional loss of Notch signaling
in peripheral T cells suggests that Notch cannot be an essential positive regulator of
Treg differentiation (Amsen et al., 2007; Amsen et al., 2004; Tu et al., 2005). Chapter 3
will discuss new findings indicating that Notch signaling acts to destabilize Treg
differentiation, with data from CD4-cre x ICN1FL/FL mice showing that activation of Notch
in T cells leads to lethal autoinflammation, consistent with a negative regulatory role for
Notch in Treg differentiation.
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CHAPTER 2: Notch simultaneously orchestrates multiple helper T cell programs
independently of cytokine signals
Abstract
Two models are proposed to explain Notch function during helper T (Th) cell
differentiation. One argues that Notch instructs one Th cell fate over the other, whereas
the other posits that Notch function is dictated by cytokines. Here we provide a detailed
mechanistic study investigating the role of Notch in orchestrating Th cell differentiation.
Notch neither instructed Th cell differentiation nor did cytokines direct Notch activity, but
instead, Notch simultaneously regulated the Th1, Th2, and Th17 cell genetic programs
independently of cytokine signals. In addition to regulating these programs in both
polarized and non-polarized Th cells, we identified Ifng as a direct Notch target. Notch
bound the Ifng CNS-22 enhancer, where it synergized with Tbet at the promoter. Thus,
Notch acts as an unbiased amplifier of Th cell differentiation. Our data provide a
paradigm for Notch in hematopoiesis, with Notch simultaneously orchestrating multiple
lineage programs, rather than restricting alternate outcomes.
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Introduction
The T helper cell program adopted by a naïve CD4+ T cell is instructed both by
extracellular molecules, such as cytokines, and intracellular molecules, such as the Th1,
Th2, and Th17 cell transcription factors, Tbet, Gata3, and Rorγt respectively. Notch has
also been proposed to mediate Th cell differentiation, where it functions to relay
intercellular signals from the membrane to the nucleus in order to instruct Th cell
differentiation (Amsen et al., 2009).
As reviewed in Chapter 1, compelling cases have been made for Notch involvement in
both Th1 and Th2 cell differentiation. Manipulating Notch ligand mediated stimulation of
CD4+ T cells preferentially instructed Th1 or Th2 cell programs, suggesting that
individual Notch ligands have different instructive capacities (Amsen et al., 2004;
Maekawa et al., 2003; Okamoto et al., 2009). Loss of function studies also demonstrated
that Notch instructed the Th1 cell program in vitro and promoted the CD4+ T cell IFNγ
response in a murine GVHD model (Minter et al., 2005; Skokos and Nussenzweig, 2007;
Zhang et al., 2011). In contrast, other reports showed that Notch was required to instruct
the Th2 but not the Th1 cell program (Amsen et al., 2007; Amsen et al., 2004; Fang et
al., 2007; Kubo, 2007; Tu et al., 2005). More recently, Notch was found to regulate the
Th17 cell signature genes Il17a and Rorc, suggesting the bi-potential instructional model
may not be sufficient to explain Notch function in Th cell differentiation (Keerthivasan et
al., 2011; Mukherjee et al., 2009). While the instructional model posits that ligands direct
Notch function during Th cell differentiation, an alternative model argues that Notch
target gene selectivity is dictated by upstream cytokine signals (Ong et al., 2008).
Despite the differences between these models, both contend that Notch has the capacity
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to discriminately activate different Th cell programs. Thus, the paradox remains: how can
such a basic signaling module selectively drive the differentiation of multiple distinct
lineages?
In order to address these controversies, we investigated the molecular mechanisms by
which Notch orchestrates Th cell differentiation. We find that Notch neither initiates a
single helper T cell program nor do cytokine signals dictate the outcome of Notch
signaling. Instead, Notch simultaneously regulates the Th1, Th2, and Th17 genetic
programs independently of cytokine signals. Even under strong polarizing conditions,
Notch directly regulates critical effectors of Th1 Th2, and Th17 cell differentiation. In
addition to Il4, Tbx21, Gata3-1a, Il17a, and Rorc, we identify Ifng as a direct Notch
target. Notch regulates Ifng by binding to a highly conserved RBPJ motif in the Ifng
CNS-22 and synergizes with Tbet activity at the Ifng promoter. These data support a
model in which Notch integrates and amplifies cytokine-derived signals, instead of acting
as a transcriptional driver or a downstream accessory of cytokines. Not only do our data
unify the disparate data on Notch and Th cell differentiation but they also offer an
alternative view of Notch function in the hematopoietic system, whereby Notch reinforces
multiple fates rather than restricting alternate outcomes.

41

Results
Notch signaling is dispensable for Th2 cell initiation during Trichuris muris infection.
We previously showed that CD4+ T cells expressing the pan-Notch inhibitor dominant
negative mastermind (DNMAML), which binds the Notch:RBPJ dimer but fails to
transactivate, do not mount an effective Th2 cell response against the intestinal helminth
Trichuris muris and fail to clear infection with normal kinetics (Tu et al., 2005). The
outcome of T. muris infection depends on the balance of Th1 cells, which are
responsible for chronic infection, and Th2 cells, which are required for parasite expulsion
and resistance to infection (Artis et al., 2004; Blackwell and Else, 2001; Cliffe and
Grencis, 2004; Cliffe et al., 2005; Else et al., 1994). While Notch was necessary for
optimal Th2 cell-dependent immunity in this infection model, it remained unclear whether
Notch was essential to initiate Th2 cell differentiation or instead, was required to
generate the optimal balance of Th1 and Th2 cells. To test this, CD4-cre (CC) and CD4cre x DNMAMLFL/FL (CCD) mice were infected with T. muris and CCD mice were treated
with neutralizing anti-IFNγ mAbs for the duration of infection. If Notch were required to
initiate Th2 cell differentiation, anti-IFNγ treated CCD mice should remain susceptible to
T. muris infection. Alternatively, if Notch played a greater role in generating an optimal
Th2 cell response, then IFNγ blockade should be sufficient to relieve any inhibitory
effects of a suboptimal Th1:Th2 ratio on infection-induced Th2 differentiation.
As expected, mesenteric lymph node cells from the control CC mice displayed robust IL4, IL-5 and IL-13 responses upon restimulation (Figure 2-1A). Consistent with our
previous findings, CCD mice demonstrated impaired Th2 cell cytokine responses (Figure
2-1A). In contrast, CCD mice receiving anti-IFNγ mAb treatment restored IL-4, IL-5, and
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IL-13 production and diminished IFNγ production, suggesting that Notch was not
required to initiate Th2 responses (Figure 2-1A). In agreement with the cytokine data,
CCD mice displayed an impaired protective T. muris specific IgG1 response and an
elevated non-protective T. muris specific IgG2c response. In contrast, anti-IFNγ mAb
treated CCD mice recovered parasite specific IgG1 and showed a trend towards
decreased IgG2c (Figure 2-1B). Similarly, while CCD mice displayed decreased serum
IgE, anti-IFNγ mAb treatment restored this response (Figure 2-1C). Furthermore,
histologic analysis of intestinal sections revealed that anti-IFNγ mAb treatment rescued
the goblet cell mucin response in CCD mice (Figure 2-1D). Finally, anti-IFNγ mAb
treatment restored the ability of CCD mice to expel parasites with kinetics comparable to
infected CC control mice by 21 days post infection (Figure 2-1E). Collectively, these data
demonstrate that Notch is not essential to initiate Th2 cell responses in vivo, and instead
suggest that Notch functions to optimize the response.
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Figure 2-1: Notch signaling is dispensable for Th2 initiation during Trichuris
muris infection. (A) At day 21, MLN from T. muris infected CC, CCD, and CCD + antiIFNγ mice were stimulated with anti-CD3 for 72 hours and cytokine levels were
measured by ELISA. (B) Serum T. muris specific IgG1 and IgG2c and (C) total IgE
were measured by ELISA from infected mice, at day 21. (D) Goblet cells in gut sections
were detected by mucin staining. (E) Worm burden at day 21 post-infection. *, P < 0.05
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Persistent Notch signaling is required to maintain the Th1 and Th2 cell programs.
To further test whether Notch is required to maintain an optimal Th2 cell response, we
investigated the effect of inhibiting Notch subsequent to Th2 cell differentiation. For
these studies, we developed an in vitro differentiation system in which Notch could be
inhibited at different times by addition of a gamma secretase inhibitor (GSI) following
activation of CD4+ T cells. This system also provided the opportunity to test the
requirement for Notch in Th1 cell differentiation. Importantly, Notch inhibition by GSI did
not affect T cell activation, proliferation, or cell numbers, even after prolonged exposure
(Figure 2-2A-C), in contrast to a recent report (Helbig et al., 2012). To look at Notch
specific effects and exclude autocrine cytokine effects, cells were cultured in the
presence of neutralizing IL-4 and IFNγ antibodies.
To test whether Notch was required post-initiation to maintain both the Th1 and Th2 cell
programs, naïve CD4+ T cells were activated in the presence of irradiated splenocytes.
After 5 days, cells were restimulated and treated with either DMSO or GSI and left in
culture for an additional 2 days (day 7) before harvest. When looking at Th1 cell
signature genes, both mRNA and protein for Tbet and IFNγ were significantly lower after
2 days of GSI treatment (Figure 2-3A-C). Similarly, GSI decreased mRNA and protein
expression of the Th2 signature genes, Gata3 and Il4 (Figure 2-3A-C).
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Figure 2-2: GSI treatment does not affect T cell activation. (WT naive CD4+ T cells
were CFSE labeled and then stimulated with irradiated splenocytes (1:5), anti-CD3e (1
µg/mL), and anti-CD-28 (1 µg/mL), cultured in media containing 5 ng/mL IL-2, 20
µg/mL anti-IL-4, and 20 µg/mL anti-IFNγ and treated with either DMSO or 1 µM GSI.
On day 5, cells were washed, restimulated, and cells previously cultured in DMSO were
either replated in DMSO or 1 µM GSI, while cells previously cultured in GSI were
maintained in GSI. (A) FACS analysis of cell proliferation on day 3 post-activation. (B)
Cell numbers on days 3, 5, and 7 post-activation. (C) FACS analysis of CD69
expression on cells days 5 and 7 post-activation. Data are represented as mean +/SEM. Related to Figure 2.
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Figure 2-3: Persistent Notch signaling is required to maintain the Th1 and Th2
programs. (A) Schematic of experimental design. WT naive CD4+ T cells were
stimulated with irradiated splenocytes, anti-CD3ε, and anti-CD28, and cultured under
neutral conditions. After 5 days, cells were restimulated as above and replated in
media containing either DMSO or 1 µM GSI. After 2 days (day 7 post-activation), (B)
RNA was then harvested and analyzed by qPCR. Cells were analyzed for (C) cytokine
production and (D) transcription factor expression by intracellular FACS.*, P < 0.05
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While our data show that persistent Notch signaling is required to maintain the Th1 and
Th2 cell programs post-initiation, it remained unclear whether the activity of Notch on
Th1 and Th2 cell targets was restricted to early patterning events or if Notch was
capable of re-activating target genes late after T cell stimulation. To address this, naïve
CD4+ T cells were activated in the presence of either DMSO or GSI, under neutralizing
conditions. After 5 days, cells were washed, restimulated, and returned to either DMSO
or GSI to test whether cells previously treated with GSI could recover cytokine and
transcription factor expression. While cells treated with GSI for all 7 days of culture
showed impaired Tbet and IFNγ induction, cells treated with GSI only for the first round
of stimulation recovered Tbet and IFNγ responses (Figure 2-4A-C). Similarly, IL-4 and
GATA3 expression decreased when cells were treated with GSI for all 7 days and
recovered when GSI was removed (Figure 2-4A-C). Our findings indicate that Notch is
capable of promoting Th1 and Th2 signature gene expression both at early and late time
points following stimulation and that inhibiting Notch at either the beginning of T cell
stimulation or at later time points represses both Th1 and Th2 cell differentiation.
Furthermore, we repeatedly observed that expression of both Th1 and Th2 cell program
genes and proteins were suppressed in the same population upon Notch inhibition,
suggesting that Notch concurrently regulates both programs. Collectively, these data
show that Notch functions in Th cell differentiation do not require upstream signals from
polarizing cytokines and demonstrate that the activity of Notch on its targets is not
kinetically restricted.
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Figure 2-4: The activity of Notch signaling during T cell differentiation is not
restricted to early activation events. (A) Schematic of experimental design. WT
naive CD4+ T cells were stimulated and cultured as above for 5 days in media
containing either DMSO or GSI. Cells were then washed and restimulated under the
same conditions, with cells previously cultured in DMSO being replated in media
containing DMSO and cells previously treated with GSI being replated in either DMSO
or 1 µM GSI. After 2 days of restimulation, (B) RNA was then harvested and analyzed
by qPCR. Cells were analyzed for (C) cytokine production and (D) transcription factor
expression by intracellular FACS. *, P < 0.05
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Notch concurrently regulates both the Th1 and Th2 programs.
Although both Th1 and Th2 cell signature genes were sensitive to GSI, it was important
to show that the effects were Notch-specific as GSI has Notch-independent effects.
Furthermore, Notch-independent, Presenilin-dependent effects on cytokine production
were reported for both Th1 and Th2 cell types (Ong et al., 2008). To test whether the
changes we observed were Notch-specific, we utilized mice containing two floxed alleles
of dominant negative mastermind (DNMAMLFL/FL), a potent and specific GFP-tagged
pan-Notch inhibitor.
Tat-Cre treated YFPFL/FL and DNMAMLFL/FL naïve CD4+ T cells were stimulated under
neutralizing conditions. Use of the Tat-Cre peptide to acutely induce DNMAML
expression minimized potential compensation for Notch signaling by other pathways. As
expected, YFP+ T cells produced IL-4 and IFNγ (Figure 2-5A). Consistent with
observations using GSI treatment, DNMAML expressing T cells displayed a marked
reduction in the fraction of cells that produced IL-4 and IFNγ confirming that Notch
regulates both IL-4 and IFNγ production in the same cell population (Figure 2-5A). In
contrast to the GSI data, analysis of Tbet and GATA3 protein in DNMAML expressing
cells revealed reduced expression of Tbet, but not GATA3 (Figure 2-5B). Notch had
been shown to regulate Tbx21 in a GSI-dependent manner and directly regulate Il4 via a
3’ enhancer; however, the GATA3 result was unexpected as Notch directly regulates
Gata3 transcription by binding to the Gata3-1a promoter in primary CD4+ T cells (Amsen
et al., 2007; Amsen et al., 2004; Fang et al., 2007; Minter et al., 2005). When transcripts
for both Th1 and Th2 signature genes were analyzed by qPCR, all four (Il4, Gata3-1a,
Ifng and Tbx21) were expressed at lower levels in DNMAML expressing cells (Figure 25C). The observed differences in GATA3 protein expression between GSI and DNMAML
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treatment were likely due to the finding that GSI suppressed transcripts from both Gata31a and Gata3-1b, whereas DNMAML only suppressed the Gata3-1a transcript, which
accounts for a minor fraction of total Gata3 transcripts (Yu et al., 2009) (Figure 2-6A-B).
These data indicate that Notch likely exerts its primary effect on the Th2 program
through its regulation of Il4. It is important to note that while DNMAML expression had no
impact on cell proliferation (Figure 2-6C), we did observe a minor increase in apoptosis
as measured by Annexin-V (Figure 2-6D). While this subtle increase cannot account for
the marked reduction in cytokine transcript and protein observed in DNMAML expressing
cells, it suggests that a role for Notch signaling in cell survival may also contribute to
these defects.
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Figure 2-5: Notch signaling is required for the expression of both Th1 and Th2
signature genes. YFPFL/FL or DNMAMLFL/FL CD4+ T cells were Tat-cre treated and
rested for 24 hours in media containing 100 ng/mL IL-7. Naive CD4+ T cells were then
FACS sorted and stimulated with irradiated splenocytes, anti-CD3ε, and anti-CD28,
and cultured under neutral conditions. After 5 days, (A) cytokine production was
measured by intracellular FACS, (B) Tbet and Gata3 protein was measured by
intracellular FACS, and (C) RNA was analyzed by qPCR. *, P < 0.05
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Figure 2-6: DNMAML expression does not affect Gata3-1b transcription or cell
viability. (A) WT naive CD4+ T cells were CFSE labeled and then stimulated with
irradiated splenocytes (1:5), anti-CD3e (1 µg/mL), and anti-CD-28 (1 µg/mL), cultured
in media containing 5 ng/mL IL-2, 20 µg/mL anti-IL-4, and 20 µg/mL anti-IFNγ and
treated with either DMSO or 1 µM GSI. RNA was harvested on day 5 post-activation
and analyzed by qPCR. (B) YFPfl/fl or DNMAMLfl/fl CD4+ T cells were Tat-cre treated
and rested for 24 hours in media containing 100 ng/mL IL-7. Naive CD4+ T cells were
then FACS sorted and stimulated with irradiated splenocytes (1:5), anti-CD3e (1
µg/mL), and anti-CD-28 (1 µg/mL), and cultured in media containing 5 ng/mL IL-2, 20
µg/mL anti-IL-4, and 20 µg/mL anti-IFNg. After 5 days, RNA was harvested and
analyzed by qPCR. (C) YFPFL/FL or DNMAMLFL/FL CD4+ T cells were Tat-cre treated and
rested for 24 hours in media containing 100 ng/mL IL-7. Naive CD4+ T cells were then
FACS sorted, labeled with CFSE, and stimulated as above under neutral conditions.
After 3 days, cell proliferation was measured by FACS. (D) FACS sorted, Tat-cre
treated, naïve CD4+ T cells from either YFPFL/FL or DNMAMLFL/FL mice were stimulated
as above under neutral conditions. Apoptosis and cell death were measured on day 5
by FACS using Annexin-V and DAPI staining.
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Our observation that both Th1 and Th2 cell signature genes were sensitive to Notch
inhibition in the same population suggested that Notch does not instruct one program
over the other, but instead acts as a global regulator. This raised the possibility that
Notch could influence both Th1 and Th2 cell signature genes, even in strongly polarizing
conditions. In order to assay direct Notch effects, we utilized the GSI-washout assay
(Weng et al., 2006). Notch targets are identified as transcripts that demonstrate GSI
sensitivity under mock wash conditions and recover upon washout in the presence of
cycloheximide.

Naïve CD4+ T cells were activated as described and cultured under strong Th1 or Th2
cell polarizing conditions. As published, both Il4 and Gata3-1a behaved as direct Notch
targets under Th2 cell polarizing conditions (Amsen et al., 2007; Amsen et al., 2004;
Fang et al., 2007) (Figure 2-7A). Unexpectedly, both of these genes behaved as direct
Notch targets under Th1 cell polarizing conditions, although the magnitude of their
expression was greatly reduced, likely due to suppression by Th1 cell culture conditions
(Figure 2-7B). Consistent with others (Minter et al., 2005), we identified Tbx21 as a
direct Notch target in Th1 cell conditioned cells, but surprisingly also observed that
Tbx21 behaved as a direct Notch target even under Th2 cell polarizing conditions
(Figure 2-7B). To confirm the unbiased behavior of Notch under polarizing conditions,
chromatin immunoprecipitation (ChIP) assays were performed. Consistent with GSIwashout results, Notch1 bound the previously reported Il4 HS5, Gata3-1a, and Tbx21
Notch1 binding sites (Figure 2-7C). The magnitude of Notch binding was similar in both
Th1 and Th2 cell polarizing conditions suggesting that the polarizing conditions do not
bias Notch binding to these critical Th1 and Th2 cell targets. This is also show
endogenous Notch1 binds Tbx21 in primary cells, confirming previous studies (Minter et
al., 2005). Together with GSI-washout data, our ChIP findings confirm that Notch
concurrently regulates both Th1 and Th2 programs, independent of cytokine signals.
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Figure 2-7: Notch concurrently regulates both the Th1 and Th2 programs. (A)
Schematic of experimental design for the GSI washout assay. WT CD4+ T cells were
stimulated as above and cultured under either Th1 or Th2 culture conditions. After 24
hours, cells were treated with either DMSO or GSI for 20 hours. Subsequently, T cells
were CD4+ MACS purified and cells cultured in DMSO were replated in DMSO and
cells cultured in GSI were either replated in GSI (Mock) or in DMSO (Washout) for 4
hours; all cells were placed in media containing CHX. (B) RNA was then harvested and
analyzed by qPCR. (C) WT CD4+ T cells were stimulated as above. After 2 days, cells
were fixed and ChIP was performed using anti-Notch1 antibody, with Nanog serving as
an internal negative control. As a negative control for the assay and antibody, antiNotch1 ChIP was performed on CD4-cre x Notch1FL/FL CD4+ T cells. *, P < 0.05
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Notch simultaneously orchestrates multiple Th cell programs by sensitizing cells to
exogenous cytokine
Having observed that Notch regulates both Th1 and Th2 cell programs, we hypothesized
that Notch could regulate these targets in other Th cell populations, such as Th17 cells.
To test this, naïve CD4+ T cells were activated as described, cultured under strong Th17
cell differentiating conditions, and subjected to the GSI-washout assay. Consistent with
Th1 and Th2 cell observations, Il4 and Tbx21 both behaved as direct Notch targets in
Th17 polarized cells (Figure 2-8A); Gata3-1a transcript was undetectable under these
conditions (data not shown). To test if Notch1 binding was conserved between Th1, Th2,
and Th17 cells, ChIP analysis was performed. In keeping with our GSI washout
observations, Notch1 bound to the Il4, Gata3-1a, and Tbx21 loci in Th17 polarized cells,
demonstrating that even though Gata3-1a was expressed at levels below the limit of
detection, Notch still occupied this region. These data illustrate that the concurrent
regulation of Th cell programs by Notch is not a unique feature of Th1 and Th2 cells, but
rather a conserved function of Notch signaling in mature, activated CD4+ T cells.
To further demonstrate that Notch functions to regulate multiple cell programs from a
common progenitor, we assayed whether the Th17 cell signature genes Il17a and Rorc
behaved as direct Notch targets, regardless of the cytokine environment. Naïve CD4+ T
cells were activated as described, cultured under Th1, Th2, or Th17 cell conditions, and
subjected to the GSI washout assay. Although the expression varied by condition, Il17a
and Rorc both behaved as direct Notch targets in all three Th cell types (Figure 2-8C).
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Figure 2-8: Notch simultaneously orchestrates multiple Th cell programs. WT
CD4+ T cells were stimulated as described under Th17 culture conditions. (A) After 24
hours, cells were treated with either DMSO or GSI for 20 hours and then subjected to a
GSI washout assay. Cells cultured in DMSO were replated in DMSO and cells cultured
in GSI were either replated in GSI (Mock) or in DMSO (Washout) for 4 hrs. RNA was
then harvested and analyzed by qPCR. (B) After 2 days, cells were fixed and ChIP was
performed using anti-Notch1 antibody, with Nanog serving as an internal negative
control. Anti-Notch1 ChIP was performed on CD4-cre x Notch1FL/FL CD4+ T cells as an
experimental and antibody negative control. (C) A GSI washout assay was performed
as above on activated CD4+ T cells cultured under either Th1, Th2, or Th17 polarizing
conditions. At the end of the assay (48 hrs), RNA was harvested and analyzed by
qPCR. (D) Naive CD4+ T cells were FACS sorted from Tat-Cre treated YFPFL/FL or
DNMAMLFL/FL CD4+ T cells. Cells were then stimulated as above, and cultured under
Th17 conditions. After 3 days, cytokine production was measured by intracellular
FACS. (E) WT CD4+ T cells were stimulated as described and then cultured in a
titration series of two-fold serially diluted Th1, Th2, or Th17 conditioned media, in the
presence of either DMSO or GSI. After 5 days, cells were restimulated and
supernatants were analyzed by ELISA two days later. *, P < 0.05
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To confirm that the observed effects on Th17 celll signature gene transcription were
biologically significant, we expressed DNMAML in naïve CD4+ T cells using Tat-Cre, as
described, and activated them under Th17 differentiating conditions. We observed at day
3 that DNMAML expression resulted in a marked reduction in the frequency of IL-17A
producing cells (Figure 2-8D).

In light of reports showing that exogenous cytokine has the capacity to rescue cytokine
production in Notch loss of function models (Amsen et al., 2004; Tu et al., 2005), we
hypothesized that an important function of Notch was to sensitize CD4+ T cells to
polarizing factors, especially when these factors may be limiting. To test this, CD4+ T
cells were activated in the presence of serially diluted Th1, Th2, or Th17 polarizing
cytokines, with media containing either DMSO or GSI. If Notch played a role in
sensitizing cells to exogenous cytokine, we would predict that Notch inhibition would
minimally affect differentiation at high levels of differentiating factors, but exert a
negative effect on differentiation when exogenous cytokines were diluted. When cells
were cultured in the presence of DMSO, secretion of IFNγ, IL-4, and IL-17A displayed an
expected dose dependent response to polarizing cytokine, with maximal cytokine
secretion observed in undiluted differentiating media (Figure 2-8E). Consistent with our
hypothesis, when cells were cultured with GSI, cells displayed similar levels of cytokine
secretion to DMSO control cells when differentiating cytokine was undiluted, but a much
more rapid and marked decay in cytokine secretion when differentiating factors became
limiting (Figure 2-8E). Altogether, these findings demonstrate that Notch simultaneously
orchestrates multiple Th cell programs by sensitizing cells to exogenous differentiating
factors.
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Notch directly regulates IFNγ expression, independently of Tbet.
As Notch regulates a Gata3:Il4 axis in Th2 cells and an Il17a:Rorc axis in Th17 cells, we
hypothesized that Notch might similarly regulate a Tbx21:Ifng axis in Th1 cells. To
confirm that Ifng is a direct Notch target, we performed a GSI washout assay on cells
cultured under strong Th1, Th2, and Th17 polarizing conditions. Similar to Gata3-1a, Il4,
and Tbx21, Ifng behaved like a direct Notch target under all three culture conditions
(Figure 2-9A).
To exclude the possibility that effects of Notch on Ifng resulted from indirect effects on
Tbx21, we inhibited Notch signaling in Tbx21-/- cells. Naïve CD4+ T cells from WT and
Tbx21-/- mice were activated and retrovirally transduced with vector control (MigR1) or
DNMAML. To obtain sufficient IFNγ expression in Tbet deficient cells, cells were cultured
in the presence of IL-12 and neutralizing anti-IFNγ and anti-IL-4 antibodies, conditions
that allow Tbet-independent IFNγ production (Schulz et al., 2009; Usui et al., 2006) and
exclude confounding paracrine effects between transduced and untransduced cells.
Transduction of either WT or Tbx21-/- cells with DNMAML decreased the fraction of cells
producing IFNγ as well as the total amount of IFNγ secreted (Figure 2-9B-C).
Collectively, these data suggest that Notch directly regulates Ifng expression,
independently of its role in regulating Tbx21, and identify Ifng as a Notch target.
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Figure 2-9: Notch directly regulates Ifng expression. (A) WT CD4+ T cells were
stimulated as described under either Th1, Th2, or Th17 culture conditions. 24 hours
later, cells were treated with either DMSO or GSI for 20 hours and then subjected to a
GSI washout assay. Cells cultured in DMSO were replated in DMSO and cells cultured
in GSI were either replated in GSI (Mock) or in DMSO (Washout) for 4 hours. RNA was
then harvested and analyzed by qPCR. (B) Schematic of experimental design. WT and
Tbet KO naive CD4+ T cells were stimulated as above and cultured with IL-12 (5
ng/mL), anti-IL-4 (20 µg/mL), and anti-IFNγ (20 µg/mL). After 24 hours, cells were
retrovirally transduced with either vector control (Mig) or DNMAML. (C) Cytokine
production was measured by intracellular FACS and (D) cytokine secretion by ELISA,
48 hours post-transduction. *, P < 0.05
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Notch1 binds to the Ifng CNS-22
To determine the mechanism by which Notch directly regulates Ifng, we searched for
RBPJ binding sites in regions known to be critical for Ifng transcription (Hatton et al.,
2006). Three RBPJ elements were identified in the Ifng CNS-22, a conserved enhancer
that is required for Ifng expression in T and NK cells (Figure 2-10A) (Hatton et al., 2006).
Primers were designed for ChIP that flanked the strongest and most conserved RBPJ
binding site in the region. Two days after stimulation, CD4+ T cells exhibited Notch1
binding at the Ifng CNS-22 (Figure 2-10B). Similar to Il4, Gata3-1a, and Tbx21 (Figure
3F), Notch1 bound the Ifng CNS-22 site in Th1, Th2, and Th17 cells (Figure 2-10B).
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Figure 2-10: Notch binds to the Ifng CNS-22. (A) Multiple species alignment of the
Ifng CNS-22 region, using NCBI DCODE.org. Highly conserved strong (red), moderate
(orange), and weak (yellow) RBPJ binding sites are highlighted. Primer sequences
used for ChIP are underlined. (B) WT CD4+ T cells were stimulated as described and
cultured under Th1, Th2, or Th17 conditions. After 2 days cells were fixed and ChIP
was performed using anti-Notch1 antibody, with Nanog serving as an internal negative
control. Anti-Notch1 ChIP on CD4-cre x Notch1FL/FL CD4+ T cells served as a negative
control for the antibody and assay.
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Notch1 and Tbet synergize to drive transcription from the Ifng CNS-22
The observation that Notch1 binds the Ifng CNS-22 suggested that Notch directly
regulates Ifng expression through this element. To test this, we utilized reporter
constructs for the Ifng CNS-22 region (Hatton et al., 2006). These constructs contain
either the minimal 468 bp Ifng promoter (ProWT) or this promoter with the Ifng CNS-22
placed upstream (CNSWTProWT). Two putative T-box half-sites were identified in the Ifng
CNS-22 fragment and mutant constructs were generated to both the upstream
(CNSMT1ProWT) and downstream (CNSMT2ProWT) T-box half-sites (Figure 2-11A) (Hatton
et al., 2006). Although the CNSMT2ProWT construct was originally described as a Tbet
binding site mutant, this same mutation also ablates the most highly conserved RBPJ
binding site in Ifng CNS-22. To test if Notch was capable of driving transcription through
the Ifng CNS-22 at this site in cells capable of endogenous IFNγ production, activated
Jurkat cells were transfected with vector control (pcDNA) or the constitutively active
Notch1 intracellular domain ICN1 (Aster et al., 2000), as well as a reporter containing
pGL3, ProWT, CNSWTProWT, or CNSMT2ProWT (Figure 2-11B). Addition of CNSWTProWT
resulted in slightly increased reporter activity that was markedly enhanced upon the
addition of ICN1, suggesting that Notch has the capacity to act on this enhancer
element. When CNSMT2ProWT was used, the increased activity observed from the
CNSWTProWT was lost and the addition of ICN1 failed to enhance reporter activity (Figure
2-11B). These data suggest that Notch1 is capable of enhancing transcription through
the Ifng CNS-22.
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Figure 2-11: Notch1 and Tbet synergize to drive transcription from the Ifng CNS22. (A) Schematic of the luciferase constructs used, as detailed in the methods. (B) 2 X
105 Jurkat cells were transfected with renilla control (pRLTK), either the ProWT,
ProWTCNSWT, or ProWTCNSMT2 luciferase reporter constructs, and either a vector
control or ICN1, using DMRIE-C liposomes. After 20 hours, cells were stimulated with
PMA and ionomycin for 4 hours. Cells were then washed and luciferase activity was
measured. (C) 2 X 104 U2OS cells were transfected with pRLTK, either the promoter
ProWT, ProWTCNSWT, ProWTCNSMT1, or ProWTCNSMT2 reporter constructs, ICN1 or vector
control, and Tbet or vector control. After 48 hours, luciferase activity was measured.
(D) 2 X 104 U2OS cells were transfected with pRLTK, either the ProWT, ProMT,
ProWTCNSWT, or ProMTCNSWT reporter constructs, ICN1 or vector control, and Tbet or
vector control. After 48 hrs, luciferase activity was measured. *, P < 0.05
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Although the Jurkat cell data established that Notch1 can drive transcription from the
Ifng CNS-22 in a mature T cell line, it remained possible that Notch1 indirectly enhanced
luciferase activity by promoting Tbx21 transcription. In addition, the loss of luciferase
activity observed when CNSMT2ProWT was expressed may have resulted from a loss of
Tbet binding, rather than the loss of RBPJ binding at the same site. To test these
alternate hypotheses, we utilized U2OS cells, which do not express endogenous Tbx21
and express very low amounts of Notch1 (data not shown). U2OS cells were transfected
with the reporter constructs described above as well as CNSMT1ProWT , which ablates the
upstream T-box half-site without disrupting the RBPJ binding site. Tbet overexpression
in U2OS cells increased luciferase activity in all constructs (Figure 2-11C). This effect
appeared primarily due to Tbet activity on the Ifng minimal promoter, as the addition of
the Ifng CNS-22 and mutation of either T-box half-site had no additional effect on
reporter activity (Figure 2-11C).

In contrast to Jurkat cells, ICN1 did not increase luciferase activity in U2OS cells,
suggesting that other factors endogenous to Jurkat cells, such as Tbet, may be required
to cooperate with Notch1 activity. Accordingly, co-expression of Tbet and ICN1
synergistically increased, luciferase activity from CNSWTProWT. Moreover, the enhanced
luciferase activity was specific to CNSWTProWT and was not observed with ProWT,
suggesting that the synergy between Notch1 and Tbet resulted from Notch1 activity at
the Ifng CNS-22 (Figure 2-11C).
To directly address this possibility, we utilized the construct in which the upstream T-box
half-site was mutated (CNSMT1ProWT). In cells expressing this reporter, luciferase activity
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was similar to the CNSWTProWT under all conditions, suggesting that the primary effect of
Tbet was through its activity on the promoter. In contrast, when the conserved RBPJ
binding site was mutated (CNSMT2ProWT), luciferase activity was comparable to the ProWT
construct (Figure 2-11C). Collectively, these data suggest that ICN1 acts at the Ifng
CNS-22 enhancer and Tbet acts at the Ifng promoter.
To directly assay the site of Tbet activity, we mutated the T-box site in the Ifng promoter
leaving the putative Tbox sites in the CNS-22 intact (Tong et al., 2005) (Figure 2-11A).
When U2OS cells were transfected with ProMT, neither Tbet alone nor Tbet plus ICN
increased reporter activity to that observed in ProWT (Figure 2-11D). Moreover, mutation
of the promoter in the context of CNS-22 (CNSWTProMT) ablated the ability of either Tbet
alone or Tbet plus ICN1 to increase reporter activity (Figure 2-11D). Overall, these data
demonstrate that binding of Notch at the Ifng CNS-22 is insufficient to activate
transcription by itself and that Tbet binding at the promoter leads to weak activation;
however, the combination of Notch binding to the CNS-22 and Tbet binding to the Ifng
promoter leads to a synergistic increase in Ifng transcription.
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Discussion
Within the lymphoid compartment, Notch is understood to selectively promote one
lineage outcome at the expense of alternate fates (Radtke et al., 2010). This instructive
paradigm was proposed to explain Th cell differentiation, however, the emerging data
are difficult to reconcile with this model as Notch promotes mutually exclusive cell fates
from a multipotential cell (Amsen et al., 2004; Maekawa et al., 2003; Minter et al., 2005;
Mukherjee et al., 2009; Tu et al., 2005). Here, we present data demonstrating that Notch
acts as an unbiased amplifier of the Th1, Th2, and Th17 cell programs by sensitizing
cells to environmental signals.
By acutely inhibiting Notch signaling under neutralizing conditions, we reveal a role for
Notch in simultaneously orchestrating both Th1 and Th2 programs. GSI treatment and
acute DNMAML expression synchronously reduced IL-4, IFNγ, and Tbet protein and
mRNA for Il4, Ifng, Tbx21, and Gata3-1a, demonstrating that Notch lacks selectivity in
regulating critical Th cell program targets. We further observed that Notch regulates
Th17 target genes even when their expression is suppressed under Th1 and Th2
conditions and vice versa. Although the polarizing conditions influence the magnitude of
gene expression, the ability of Notch to bind these key loci was unchanged, illustrating
that the cytokine environment does not impact the ability of Notch to regulate its targets.
Accordingly, our work suggests that Notch plays a critical role in reinforcing Th cell
differentiation at physiologic levels of cytokine signaling, which would be important early
during immune responses when differentiating cytokine cues are limiting. In addition,
these findings help reconcile conflicting reports in the literature that emphasized the
ability of Notch to preferentially regulate specific Th programs.
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In related work, Ong et al. contended that Notch signaling itself had minimal impact on
Th differentiation, but rather upstream cytokine signals directed Notch to selectivity
enhance individual Th responses (Ong et al., 2008). Consistent with our findings, these
studies argued that Notch lacks instructive capacity. Our T. muris studies provide the
first in vivo loss-of-function data confirming that Notch is not required for instruction,
however our GSI-washout and ChIP data provide a distinct mechanistic view of Notch
function during Th differentiation. Rather than requiring cytokine signals to condition
Notch selectivity, we find that Notch binds and regulates target loci without regard to
cytokine signals. Moreover, we further show that Notch concurrently regulates Th cell
programs even under neutralizing conditions. Thus, our work suggests that the activity of
Notch is not dictated by cytokine signaling, but rather that Notch simultaneously
facilitates transcription of multiple programs regardless of polarizing cues.
In addition to providing a unifying model for Notch in Th cell differentiation, we present
definitive genetic loss-of-function and molecular data evincing a role for Notch in the Th1
program. Not only do our data demonstrate for the first time that endogenous Notch1
binds Tbx21 and that Tbx21 is a direct Notch target in primary CD4+ T cells, but we also
show that Ifng is a novel, direct Notch target, independent of Notch’s role in regulating
Tbx21. While the Notch effects on Ifng are independent of its activity on Tbx21, Notch
does not appear capable of driving Ifng transcription by itself, consistent with a model in
which Notch lacks the capacity to instruct Th differentiation. Both factors are needed for
optimal Ifng expression, where they bind different regulatory elements. Moreover, the
Tbx21-/- studies suggest that Notch is capable of collaborating with factors other than
Tbet, as DNMAML suppressed Ifng expression in its absence. The original report using
these luciferase constructs found that Tbet overexpression was capable of enhancing
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luciferase activity of the WT CNS-22 construct when cells were stimulated with PMA and
ionomycin (Hatton et al., 2006), which also induces NFκB binding to the Ifng CNS-22
(Balasubramani et al., 2010). As the Ifng CNS-22 contains multiple regulatory motifs,
these data suggest that Tbet activity at the Ifng promoter synergizes with multiple factors
regulating the Ifng CNS-22, including Notch and NFκB. Altogether, these data illustrate
the dynamism of the Ifng promoter and CNS-22 and demonstrate how these elements
have the potential to integrate inputs from multiple pathways.
The results of our reporter assays are reminiscent of the synergy between Gata3 and
Notch1 at the Il4 locus and suggest that Notch and cytokine signaling collaborate in both
Th1 and Th2 differentiation (Fang et al., 2007). Furthermore, Notch appears to
participate in a feed-forward loop, promoting Tbx21 transcription and in turn synergizing
with Tbet protein to enhance Ifng transcription. Work by Flavell and colleagues suggests
that this Th1 feed-forward loop must be stabilized by other factors (Amsen et al., 2007).
In their study, constitutive Notch signaling was insufficient to enforce Th1 differentiation
in the presence of endogenous Gata3, demonstrating that low levels of Gata3 act as a
failsafe against runaway Th1 differentiation in response to Notch activation. In addition to
transcriptional regulation, Notch can regulate IFNγ secretion in an RBPJ-independent
manner, suggesting that Notch regulates the CD4+ T cell IFNγ response at multiple,
mechanistically distinct levels (Auderset et al., 2012). Additionally, a recent human T cell
study implicated a role for Notch in Th1 differentiation (Le Friec et al., 2012). Together,
these data firmly establish Notch as a key regulator of the Th1 program.
As well as revealing a definitive role for Notch in promoting Th1 differentiation, our data
further clarify the mechanism by which Notch regulates Th2 differentiation. The findings
from anti-IFNγ mAb treated T muris infected CCD mice indicate that the role of Notch
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during in vivo Th2 inflammation is similar to what has been reported for NFκB2, IL-25,
and TSLP (Artis et al., 2002; Owyang et al., 2006; Taylor et al., 2009). Like Notch, mice
deficient for each of these factors displayed susceptibility to helminth infection and
impaired Th2 immune responses, however blockade of Th1 responses in these mouse
models resulted in restoration of the Th2 response and worm expulsion. Moreover,
unlike the role for Notch in regulating Th1 differentiation, we observe a major role for
Notch in promoting IL-4 production but minimal impact on total Gata3, suggesting that
additional factors, such the Notch target Tcf1, may be required to fully engage the Th2
program (Yu et al., 2009). These studies collectively illustrate a clear distinction between
Th2 initiating factors, such as NFκB1 (Artis et al., 2002), and the multiple inputs that
maintain an optimal Th2 response in vivo, but are dispensable for Th2 program initiation,
such as Notch.
In addition to regulating Notch-dependent IL-4 production in Th2 cells, recent work
demonstrated that the IL-4 HS5 region is critical for T follicular helper cell (Tfh)
production of IL-4 (Harada et al., 2012; Vijayanand et al., 2012). These findings raise
the possibility that Notch inhibition in the T. muris studies may impact both Th2 and Tfh
subsets during infection and the combined effects on these two populations contribute to
the phenotype observed. Importantly, anti-IFNγ treatment restored productive immunity
against helminth infection; and therefore, the role that Notch signaling plays in Tfh
biology is either redundant with its function in Th2 cells or not essential for Tfh
differentiation, similar to what we observe for Th1, Th2, and Th17 subsets.
With the recent recognition of Th cell plasticity, particularly at early time points, our data
suggest that Notch functions to ensure that activated CD4+ T cells overcome a Th cell
commitment threshold (Murphy and Stockinger, 2010). In this manner, Notch tunes the
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responsiveness of an activated CD4+ T cell to a specific Th cell program by sensitizing
cells to limiting environmental differentiation cues. Thus, depending on the inflammatory
environment for a given immune response, the requirement for Notch will vary
depending on whether the strength of the differentiating signals a T cell receives are
sufficient to achieve a signaling threshold for Th cell commitment. For example, during T.
muris infection, our model argues that Notch sensitizes T cells to limiting Th2
differentiating cues, while residual IFNγ signals destabilize the Th2 circuitry when Notch
signaling is abrogated. This model would also explain why Th1 differentiation occurs
independently of Notch during Leishmania infection, as we would predict that the
environmental differentiating signals are sufficient to overcome a commitment threshold
(Amsen et al., 2004; Tu et al., 2005). Alternatively, in the context of GvHD, which is
characterized by a mixed Th cell response, Notch is required to sensitize cells to
subthreshold signals and achieve optimal IFNγ production (Zhang et al., 2011). While
our data favor a model in which Notch regulates Th differentiation by sensitizing cells to
their environment, Notch likely plays additional roles in other aspects of Th biology, such
as survival and metabolism, that warrant future study.
Overall, these findings offer a paradigm for Notch in the immune system. In addition to
its roles as an arbiter of alternate fate decisions and a key regulator of cell survival,
proliferation, and metabolism, we reveal that Notch also acts to potentiate multiple fates
from a single progenitor. Not only does this paradigm reconcile previously conflicting
studies, but it also suggests that manipulating the amounts of Notch signaling in Th cell
mediated pathologies may have therapeutic benefit.
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CHAPTER 3: Notch signaling lacks instructional or oncogenic activity post-βselection

Abstract
Notch signaling is classically understood to instruct cell fates during development and to
drive oncogenesis when hyperactivated during hematopoiesis. Enforced activation of
Notch signaling in bone marrow progenitors or T lineage precursors prior to the βselection checkpoint instructs T lineage development and drives T cell acute
lymphoblastic leukemia. Here we find that activation of Notch signaling after β-selection
fails to instruct cell fates and does not promote leukemia. Instead, mice develop a lethal
autoinflammatory disorder. This disease results from the ability of Notch signaling to
concurrently promote Th1, Th2, and Th17 cell differentiation. Moreover, this study
reveals a novel role for Notch signaling in destabilizing Treg differentiation. Notch
signaling acts to desensitize T cells to TGFβ, such that inhibiting Notch signaling
promotes Treg differentiation in non-permissive conditions. Notch’s dual role in
promoting inflammatory Th cell differentiation and destabilizing Treg differentiation
makes it a key regulator of the Th9-Treg and Th17-Treg axes and an attractive
therapeutic target for inflammatory disorders. Altogether these findings highlight a loss in
oncogenic potential for Notch signaling after β-selection and evince a non-instructional
paradigm for Notch signaling in late-stage T lineage development .
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Introduction
Chapter 2 presented work showing that the Notch pathway has the capacity to sensitize
activated CD4+ T cells, in an unbiased fashion, to environmental differentiation signals
that promote inflammatory Th cell programs(Bailis et al., 2013). In this manner, Notch
signaling is required for Th cell mediated inflammation in the context of diseases that are
characterized by mixed-cytokine responses, such as Trichurus muris infection or graftversus-host disease, but is not essential for diseases characterized by the efficient and
dominant differentiation of a single Th cell response, such as Listeria major(Tu et al.,
2005; Zhang et al., 2011). Unlike obligate factors, such as cytokines and co-stimulatory
receptors, that have the capacity to instruct a given program and/or activate CD4+ T
cells, these findings place Notch receptors in a unique category of auxiliary factors that
act to boost local activating and differentiating cues in a nondiscriminatory manner.

In contrast to its unbiased role in Th cell differentiation, Notch signaling is classically
understood to play an essential function in instructing cell fate decisions(Radtke et al.,
2013). Within the hematopoietic compartment, Notch signaling is best known for its role
in instructing T lineage development at the expense of B cells. To this end, enforced
activation of the Notch pathway has been shown to potently drive T lineage commitment
when the constitutively active intracellular Notch (ICN) domain is expressed in
hematopoietic and early-T progenitors(Radtke et al., 2013). Moreover, high levels of
sustained Notch signaling drive an oncogenic program that leads to the onset of T cell
acute lymphoblastic leukemia (T-ALL)(Aster et al., 2011). In the peripheral T cell
compartment, expression of ICN has been reported to selectively drive Th1 and Th2 cell
differentiation(Amsen et al., 2007; Fang et al., 2007; Maekawa et al., 2003; Minter et al.,
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2005). Thus it remains possible that the Notch pathway behaves instructionally and/or
signaling outcome is dictated by signal dose: such that at limiting concentrations, Notch
acts in an unbiased manner, whereas above a certain threshold, the Notch pathway
displays its classical instructional activity.

In order to substantiate our loss-of-function in vitro findings and test whether the
outcome of Notch signaling is merely dictated by signal dose, we bred CD4-Cre mice to
mice homozygous for a flox-stopped ICN allele (ICNF/F), such that the Notch pathway is
constitutively active in all T-lineage cells from the double positive (DP) stage of
thymocyte development onward. All previous gain-of-function Notch studies have been
performed using bone marrow progenitors or conditional models that induce Notch
activation before the β-selection checkpoint of thymocyte development. In these models,
activation of the Notch pathway instructs T cell development and drives T-ALL
onset(Allman et al., 2001; Bellavia et al., 2000; Bellavia et al., 2002; Deftos et al., 2000;
Pear et al., 1996; Pui et al., 1999; Robey et al., 1996). If Notch signal dose determines
whether the Notch pathway behaves instructionally, then expression of ICN in DP
thymocytes should lead to either T-ALL onset, the selective induction of a single Th cell
program, or both. If Notch signaling acts by fundamentally distinct mechanisms in early
and late T-lineage development, then the unbiased activity of Notch observed in our
loss-of-function studies should manifest itself in these mice.

Unlike previously reported gain-of-function Notch signaling models in early T-lineage
progenitors, activation of the Notch pathway after β-selection does not lead to T-ALL
onset. In contrast, CD4-Cre x ICNF/F (NIC) mice succumb to a lethal autoinflammatory
disorder, mediated by CD4+ T cells and characterized by skin necrosis, multi-organ
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inflammation, and wasting. Rather than promoting the differentiation of a single Th cell
program, persistent Notch signaling simultaneously promotes the differentiation of Th1,
Th2, and Th17 cells, in keeping with loss-of-function findings. Furthermore, these studies
reveal a novel role for Notch signaling in destabilizing regulatory T (Treg) cell
differentiation by desensitizing activated CD4+ T cells to TGFβ-derived signals, making
Notch a key regulator of the Th17-Treg and Th9-Treg axes and an attractive therapeutic
target for diseases resulting from CD4+ T cell-mediated inflammation. Altogether, these
findings support a model in which the Notch pathway exerts distinct mechanistic
functions in early and late in T cell development.
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Results
Enforced Notch signaling post-β-selection induces a lethal autoinfllammatory disorder,
while failing to drive T-ALL
To test the consequences of constitutive Notch signaling in post β-selection T cells, we
bred CD4-Cre mice to ICN1FL/FL mice (Figure 1A), which maintains Notch signaling in T
cells after β-selection. In contrast to models in which ICN1 is expressed before βselection, CD4--ICN1 mice fail to develop T-ALL. Instead, these mice die by 200 days of
age from a disease process characterized by a severe systemic autoinflammatory
disorder (Figure 3-1B). CD4-cre x ICN1 mice display severe skin necrosis, colitis, and
cachexia (Figures 3-1C-D). Additionally, these mice exhibit hepatosplenomegaly and
small thymi (Figures 3-1E-F). Histopathologic analysis revealed extensive granulocytic
infiltrates in the colon, liver, spleen, lymph nodes, and bone marrow (Figure 3-2A).
Furthermore, these granulocytic infiltrates disrupted the normal tissue architecture
(Figures 3-2B-C). Altogether, these data suggest that persistent Notch signaling post-βselection induces a lethal, autoinflammatory disorder.
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Figure 3-1: CD4-Cre x ICN1FL/FL mice develop a lethal autoinflammatory disease.
(A) Schematic of transgenic alleles for CD4-Cre and ICNFL/FL mice. (B) Kaplan-Myer
survival curve of CD4-Cre and CD4-Cre x ICNFL/FL mice. (C) Representative picture of
CD4-Cre x ICNFL/FL mice. (D) Body weight, (E) spleen weight, and (F) thymus weight of
CD4-Cre and CD4-Cre x ICNFL/FL mice.
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Figure 3-2: CD4-Cre x ICN1FL/FL mice display severe neutrophilia and granulocyte
infiltration (A) Flow cytometry of neutrophils in spleen, lymph node, and bone marrow
of CD4-Cre and CD4-Cre x ICNFL/FL mice. (B) Histology of liver and colon sections from
CD4-Cre and CD4-Cre x ICNFL/FL mice with H&E staining.
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Helper T cells are responsible for mediating the autoinflammation observed in CD4-Cre
x ICN1 mice
Although CD4-Cre activates Notch signaling in post β-selection T cells, it remained
possible that the disease observed originated from indirect affects on non-T lineage
populations. To confirm that the autoinflammatory phenotype was due to Notch signaling
within the T cell compartment, 1 x 106 purified T cells or T-depleted splenoyctes from
either CD4-Cre x YFPFL/FL or ICN1 mice were adoptively transferred into WT mice.
Granulocyte frequency was tracked as a biomarker for disease and three weeks posttransplant, we assessed neutrophil content in the spleens of recipient mice. Even though
the adoptively transferred cells were only a small fraction of circulating leukocytes in the
WT recipient mice, T cells from CD4-Cre x ICN1 mice were sufficient to induce
increased neutrophil recruitment, whereas CD4-Cre x YFPFL/FL T cells and non-T cells
from either group failed to affect granulocyte frequency (Figure 3-3A).

To further resolve the population of cells responsible for mediating the autoinflammation
observed in CD4-Cre x ICN1mice, we tested the ability of CD4+ and CD8+ T cell subsets
to of transfer disease. CD4+ or CD8+ T cells were FACS sorted from either CD4-Cre x
YFPFL/FL or CD4-Cre x ICN1 mice and 1 x 106 cells were transferred to WT mice. After
four weeks, granuloctye frequency was assessed in the spleens of recipient mice. While
CD8+ T cells from both groups and CD4+ T cells from CD4-Cre x YFPFL/FL mice displayed
normal levels of splenic granulocytes, CD4+ T cells from NIC mice were sufficient to
induce granulocyte accumulation (Figure 3-3B). These data suggest that Th cells from
CD4-Cre x ICN1 mice are the primary driver of disease.
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Figure 3-3: CD4+ T cells mediate disease in CD4-Cre x ICN1FL/FL mice. (A) T cells or
T-depleted cells from CD4-Cre x YFPFL/FL or CD4-Cre x ICNFL/FL mice were adoptively
transferred into WT mice. Neutrophil frequency in the spleens of recipient mice was
analyzed by flow cytometry, three weeks post transfer. B6 mice were used as a normal
control. (B) CD4+ and CD8+ T cells from CD4-Cre x YFPFL/FL or CD4-Cre x ICNFL/FL were
adoptively transferred to WT mice. Neutrophil frequency in the spleens of recipient mice
was analyzed by flow cytometry, four weeks post transfer.
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Enforced Notch expression in peripheral T cells concurrently promotes Th1, Th2, and
Th17 differentiation
Having identified ICN1-expressing Th cells as the principal disease mediator, we sought
to characterize the cytokine response of CD4-Cre x ICN1 CD4+ T cells. In contrast to
previous reports that constitutive Notch1 signaling in hematopoietic progenitors or CD4+
T cells selectively instructs a single differentiation program(Amsen et al., 2007; Fang et
al., 2007; Maekawa et al., 2003; Minter et al., 2005), our genetic model of enforced
Notch signaling increased Th1, Th2, and Th17 differentiation (Figure 3A-B). Ex vivo
stimulation of CD4-Cre x YFPFL/FL or CD4-Cre x ICN1 T cells with PMA and ionomycin
revealed that CD4-Cre x ICN1 Th cells increased IL-4, IFNγ, and IL-17A production.
Moreover, CD4-Cre x ICN1 Th cells spontaneously produced all three cytokines in the
absence of stimulation, in contrast to control cells, indicating that Notch signaling
concurrently promotes multiple inflammatory Th cell programs, findings that are
consistent with loss-of-function findings(Bailis et al., 2013),.

To verify that the increase in signature cytokine production of all three inflammatory Th
subsets reflected bona fide Th cell differentiation and not an unstable, poly-activated
state, we attempted to re-differentiate CD4-Cre x ICN1 T cells in vitro under Th1 or Th2
conditions. If hyperactivation of Notch signaling resulted in a broad increase in cytokine
production by T cells, but not true Th cell differentiation, then it should be possible to
differentiate these cells to a single program under stringent Th1 or Th2 conditions.
Additionally, if Notch signaling has any instructional bias toward a single program, it
should revealed under these robust differentiating conditions. That is, if Notch has
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instructional bias toward Th2 differentiation we should see synergy under Th2 conditions
and retained IL-4 production under Th1 conditions, but not visa-versa. As expected,
control T cells displayed a mixture of IL-4 and IFNγ production under non-differentiating
Th0 conditions, only IFNγ production under Th1 conditions, and only IL-4 production
under Th2 conditions (Figure 3C). In contrast, CD4-Cre x ICN1T cells display an
increased capacity to produce both IL-4 and IFNγ under all three conditions (Figure 3C).
Not only do CD4-Cre x ICN1 T cells retain IL-4 production under Th1 conditions and
IFNγ under Th2 conditions, indicating that these are bona fide Th1 and Th2 differentiated
cells, but these cells increased the IL-4, IFNγ double-producing population regardless of
conditions, further supporting a role for Notch as an unbiased amplifier of multiple Th cell
programs (Figure 3C).
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Figure 3-4: CD4+ T cells from CD4-Cre x ICNFL/FL mice display spontaneous
production of IL-4, IFNγ, and IL-17A. Lymph node cells from CD4-Cre or CD4-Cre x
ICNFL/FL mice were either left unstimulated or activated with PMA and ionomycin for 5 hrs
and then analyzed by intracellular flow cytometry for (A) IL-4 and IFNγ or (B) IL-17A. (C)
CD4+ T cells from CD4-Cre or CD4-Cre x ICNFL/FL mice were stimulated with irradiated
splenocytes, anti-CD3ε, and anti-CD28, and cultured under Th0, Th1, or Th2 conditions.
After 5 days, cells were restimulated with PMA and ionomycin and analyzed by
intracellular flow cytometry for IL-4 and IFNγ production.
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Notch signaling potentiates the differentiation of multiple inflammatory Th cell subsets in
a cell-autonomous manner
While our adoptive transfer studies indicate that small numbers of CD4-Cre x ICN1 T
cells are sufficient to transfer hallmarks of the disease observed in CD4-Cre x ICN1 mice
to WT recipients, it remained possible that the hyper-activation of these Th cells was
secondary to Notch activation in another cell type or due to the absence of a normal T
cell population. To address this, bone marrow cells from either SJL controls, CD4-Cre x
ICN1 mice, or a 1:1 mix from SJL and NIC mice were transferred into lethally irradiated
RAG2-/- recipients. In contrast to SJL bone marrow recipients that were grossly normal,
both CD4-Cre x ICN1 and SJL/NIC mix recipients developed disease. CD4-Cre x ICN1
bone marrow chimeras exhibited weight loss, thymic involution, and neutrophilia, with
SJL/NIC mixed chimeras showing comparable thymic atrophy and elevated granulocyte
numbers and a trend toward a decrease in weight (Figure 3-5A-D).

As both CD4-Cre x ICN1 and SJL/ CD4-Cre x ICN1 bone marrow chimeras developed
disease similar to that observed in CD4-Cre x ICN1 mice, we next tested whether ICN1
expression in CD4+ T cells from these bone marrow chimeras also promoted the
differentiation of multiple Th cell subsets. Splenocytes from SJL, CD4-Cre x ICN1, and
SJL/ CD4-Cre x ICN1 mixed bone marrow chimeras were stimulated ex vivo with PMA
and ionomycin and cytokine production was assessed by intracellular flow cytometry.
Restimulated SJL CD4+ T cells demonstrated the capacity to produce both IFNγ and IL2, but minimal capacity to produce IL-4 or IL-17A (Figure 3-5E). SJL, GFP-CD4+ T cells
from SJL/ CD4-Cre x ICN1 mixed chimeras also displayed IFNγ and IL-2 production and
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a limited capacity to produce IL-17A, but showed an increased capacity to produce IL-4,
compared to SJL single chimeric CD4+ T cells, suggesting that the presence of CD4-Cre
x ICN1 T cells in the mixed chimera culture affected cytokine production by SJL cells in
trans (Figure 3-5E). Unlike SJL cells from either culture, GFP+CD4+ T cells from both
CD4-Cre x ICN1 single chimeras or SJL/ CD4-Cre x ICN1 mixed chimeras displayed an
increased capacity to produce all four cytokines, including the emergence of IL-4+IFNγ+
and IL-17A+IL-2+ multi-cytokine producing populations, consistent with a role for Notch in
concurrently promoting multiple Th cell programs (Figure 3-5E). Altogether, these data
indicate that the disease observed in CD4-Cre x ICN1 mice is T cell autonomous and
that the CD4-Cre x ICN1 CD4+ T cell poly-differentiated phenotype cannot be promoted
in trans.
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Figure 3-5: T cell defects in CD4-Cre x ICNFL/FL are cell autonomous. Bone marrow
cells from SJL, CD4-Cre x ICNFL/FL, or both SJL and CD4-Cre x ICNFL/FL mice were
adoptively transferred into lethally irradiated SJL recipients. After 6 weeks, mice were
analyzed. (A) Body weight of recipient mice. (B) Total thymocytes number in recipient
mice. (C) Absolute number of neutrophils in spleens of recipient mice. (D) Neutrophil
frequency in spleens of chimeric mice. (E) Lymph node cells from recipient mice were
stimulated ex vivo with PMA and ionomycin and analyzed by intracellular flow cytometry
for the production of IL-4, IFNγ, IL-17A, and IL-2.
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Notch signaling destabilizes the initiation, but not the maintenance, of Treg differentiation
In addition to causing autoinflammation by promoting the differentiation of multiple
inflammatory Th cell subsets, it remained possible that Notch signaling further
exacerbated this phenotype by destabilizing Treg cell differentiation. To address this, we
assessed the Treg content of CD4-Cre x YFPFL/FL and CD4-Cre x ICN1 mice by flow
cytometry. In both the thymus and spleen of CD4-Cre x ICN1 mice, the Foxp3+ Treg cell
population was decreased, suggesting that CD4-Cre x ICN1 Treg differentiation might be
less efficient (Figures 5A-B). To test whether CD4-Cre x ICN1 T cells were refractory to
Treg differentiation, CD4+ T cells from either CD4-Cre x YFPFL/FL or CD4-Cre x ICN1
mice were activated in vitro under Treg polarizing conditions and Foxp3 expression was
assessed after five days. While CD4-Cre x YFPFL/FL T cells were capable of inducing
Foxp3 expression, CD4-Cre x ICN1 T cells were refractory to Treg differentiation,
consistent with in vivo findings (Figure 3-6C).

We next sought to establish whether the decreased Treg capacity in CD4-Cre x ICN1
CD4+ T cells was cell autonomous, or secondary to the Notch pathway’s ability to
promote multiple inflammatory Th cell subsets. Splenocytes from SJL, CD4-Cre x ICN1,
or SJL/ CD4-Cre x ICN1 mixed bone marrow chimeric mice were analyzed by flow
cytometry for Foxp3 expression. Whereas SJL bone marrow recipients exhibited an
appreciable Treg population, Foxp3+ cells were nearly absent in CD4-Cre x ICN1
chimeras (Figure 3-6D-E). Similarly, the GFP+ CD4-Cre x ICN1 compartment in SJL/
CD4-Cre x ICN1 mixed bone marrow chimeras displayed a paucity of Tregs and reduced
frequency compared to CD45.1+ SJL cells in the same mice, indicating that this
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phenotype was likely cell autonomous. These mice also demonstrated a trend toward
decreased Tregs within the CD45.1+ SJL compartment, albeit still greater than observed
amongst GFP+ cells, indicating that the Treg deficiency phenotype may be in part due to
trans effects from the enhanced cytokine production by CD4-Cre x ICN1 T cells (Figure
3-6D-E).

To exclude the possibility that the decreased Treg cell population in the CD4-Cre x ICN1
mice resulted from being exposed to an environment of excess cytokine production, we
utilized a Tat-Cre model. This system allows for transient and acute Cre-mediated
deletion, thus permitting us to study ICNFL/FL T cells that develop in an otherwise WT
environment in vivo and then can be induced to express ICN1 in vitro. CD4+ T cells from
either YFPFL/FL or ICN1FL/FL were treated with Tat-Cre and rested overnight, after which
naïve YFP+/GFP+ T cells were sorted and activated under Treg polarizing conditions. As
expected, YFPFL/FL cells were capable of initiating Foxp3 expression under these
conditions. In contrast, ICN1FL/FL T cells displayed a decreased Treg differentiation
capacity, indicating that the inflammation present in CD4-Cre x ICN1mice is not the
primary cause for the loss in Treg differentiating capacity (Figure 3-6E).

Having confirmed that enforced Notch1 signaling is sufficient to impair Treg
differentiation in a cell autonomous manner, we asked whether Notch1 signaling
inhibited the initiation of the Treg program or acted to destabilize the maintenance of the
Treg identity. To address this, Foxp3-Cre mice were bred to either YFPFL/FL or ICN1FL/FL
mice, such that constitutive Notch signaling is induced after the Treg program has been
initiated. Naïve CD4+ T cells from either Foxp3-Cre x YFPFL/FL or Foxp3-Cre x ICN1FL/FL
mice were activated under Treg polarizing conditions and Foxp3 expression was
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assessed by intracellular flow cytometry. Unlike the CD4-Cre or Tat-Cre models, in
which ICN1 expressing cells were refractory to Treg differentiation, Foxp3-Cre x YFPFL/FL
and Foxp3-Cre x NICFL/FL exhibited a comparable capacity for Treg differentiation in this
model, indicating that once Foxp3 expression is initiated, Notch signaling is no longer
sufficient to destabilize the Treg program (Figure 3-6F). Thus, Notch signaling acts to
impair the initiation of Treg differentiation.
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Figure 3-6: Impaired Treg induction in CD4-Cre x ICNFL/FL mice. (A) Frequency of
CD4+Foxp3+ cells in the (A) thymus and (B) spleen of CD4-Cre x YFPFL/FL, CD4-Cre x
DNMAMLFL/FL, and CD4-Cre x ICNFL/FL mice. (C) CD4+ T cells from CD4-Cre or CD4Cre x ICNFL/FL mice were stimulated as above under Treg polarizing conditions. After 5
days, cells were analyzed by flow cytometry for Foxp3 expression. Bone marrow cells
from SJL, CD4-Cre x ICNFL/FL, or both SJL and CD4-Cre x ICNFL/FL mice were adoptively
transferred into lethally irradiated SJL recipients. (D) Absolute numbers of splenic Tregs
and (E) frequency was assessed by flow cytometry. (F) CD4+ cells from YFPFL/FL and
ICNFL/FL mice were treated with Tat-Cre, rested for 24 hours, and then YFP+ or GFP+
CD4+ T cells were sorted. T cells were then stimulated as above under Treg polarizing
conditions. After 5 days, cells were analyzed by intracellular flow cytometry for Foxp3
expression. (G) CD4+ T cells from Foxp3-Cre x YFPFL/FL and Foxp3-Cre x ICNFL/FL mice
were stimulated as above under Treg polarizing conditions. After 5 days, Foxp3
expression was analyzed by flow cytometry.
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Notch signaling desensitizes activated CD4+ T cells to TGF-β and is a key regulator of
the Th9-Treg and Th17-Treg axes

We previously demonstrated that Notch signaling acts to potentiate multiple
inflammatory Th cell programs by sensitizing activated CD4+ T cells to inflammatory
differentiating cues. Because enforced Notch1 signaling destabilized Treg differentiation,
we hypothesized that the Notch pathway might similarly desensitize activated CD4+ T
cells to TGF-β, the primary Treg differentiating factor. To test this hypothesis, we
activated WT naïve CD4+ T cells in the presence or absence of the pharmacological
Notch inhibitor GSI (γ-secretase inhibitor), under a series of serially diluted TGF-β
concentrations, with IL-2 being held constant. Predictably, as TGF-β was titrated down,
decreased Treg differentiation was observed in vehicle control treated (DMSO) cultures
(Figure 3-7A). In contrast, Notch-inhibited cultures were resistant to decreased TGF-β
concentrations and maintained robust Treg differentiating capacity even in 64-fold
diluted TGF-β, where minimal Foxp3 expression is observed in control cultures (Figure
3-7A). As both IL-4 and IFNγ can destabilize Treg differentiation and inhibition of Notch
signaling results in decreased production of both these ctyokines, the ability of GSI
treatment to stabilize Treg differentiation in limiting TGF-β may merely result from
decreased IL-4 and IFNγ in these culture. To exclude this possibility, we repeated the
TGF-β titration cultures in the presence of neutralizing anti-IL-4 and anti-IFNγ antibodies.
While DMSO treated cultures displayed decreased Treg differentiation as TGF-β
concentrations became limiting, GSI treated cultures displayed high levels of Treg
differentiation at concentrations that failed to support this population in control conditions
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(Figure 3-7B). It is worth noting that the effect of GSI at lower TGF-β concentrations was
not as robust when neutralizing antibody was present, suggesting that while the
dominant effect of Notch inhibition is TGF-β-desensitization, loss of inflammatory
cytokine production likely also contributes.

To verify that the enhanced TGF-β sensitivity observed in GSI treated cultures was due
to effects on the Notch pathway and not another γ-secretase-dependent process, we
repeated the TGF-β titration assay using either Tat-Cre treated YFPFL/FL or DNMAMLFL/FL
CD4+ T cells. Similar to GSI treatment, DNMAML expressing T cells retained an
elevated Treg differentiating capacity at limiting doses of TGF-β, whereas YFPFL/FL cells
lost Foxp3 expression as TGF-β was diluted in the culture (Figure 3-7C). These data
indicate that while Notch signaling sensitizes activated T cells to inflammatory
differentiating cues, it concurrently acts to desensitize these cells to TGF-β-derived
signals, thus providing a mechanistic basis for the Treg phenotype observed in ICN1
mice.
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Figure 3-7: Notch signaling desensitizes activated T cells to TGFβ. WT CD4+ T cells
were stimulated as described and then cultured in the presence of either DMSO or GSI
with media containing (A) a titration series of four-fold serially diluted TGFβ and constant
IL-2 or (B) or the same titration series plus anti-IL-4 and anti-IFNγ. After 5 days, cells
were analyzed for Foxp3 expression by intracellular flow cytometry. (B) CD4+ cells from
YFPFL/FL and DNMAMLFL/FL mice were treated with Tat-Cre, rested for 24 hours, and then
YFP+ or GFP+ CD4+ T cells were sorted. T cells were then stimulated and then cultured
in a titration series of four-fold serially diluted TGFβ and constant IL-2. After 5 days, cells
were analyzed by intracellular flow cytometry for Foxp3 expression.
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Given the Notch pathway’s unique role in regulating T cell sensitivity to both
inflammatory and regulatory cues, we predicted that this would place Notch as a key
regulator of the Th17-Treg and Th9-Treg axes. The inflammatory Th subsets, Th17 and
Th9, each require the presence of both TGF-β and the inflammatory cytokines IL-6 and
IL-4, respectively, to initiate their differentiation programs. Thus, as inflammatory
cytokines become limiting, Notch signaling should regulate a switch in the choice
between an inflammatory or regulatory Th cell fate under these complex cytokine
conditions. We previously showed that when IL-6 is serially diluted from Th17 conditions
in the presence of GSI that IL-17A production is rapidly lost, compared to vehicle control,
however it remained unclear if Notch inhibition can still promote Treg differentiation in
conditions that favor inflammatory Th cell differentiation.

To test our hypothesis, naïve CD4+ T cells from WT mice were activated under either
Th17 or Th9 conditions, with IL-6 and IL-4, respectively, being serially diluted and TGF-β
held constant. As expected, titrating IL-6 from the culture in the presence of DMSO
resulted in increased Foxp3 expression (Figure 3-8A). When these cells were cultured in
the presence of GSI, Foxp3 expression was more readily induced and expressed in a
greater fraction of cells at all IL-6 concentrations, suggesting that Notch inhibits Treg
differentiation and stabilizes Th17 differentiation in order to lower the cytokine threshold
for commitment (Figure 3-8A).

Similar to titrating IL-6, serial dilution of IL-4 resulted in a gradual decrease in Gata3
expression and eventually complete destabilization of Th9 differentiation at 256-fold
diluted IL-4 (Figure 3-8B). Unlike Th17 differentiation, which was more readily
destabilized at lower concentrations of IL-6, Th9 differentiation remained remarkably
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stable when Notch signaling was permitted, with Gata3 being expressed in nearly all
cells until IL-4 was markedly diluted. In contrast, when Notch signaling was inhibited,
Th9 differentiation was markedly destabilized. Gata3 expression was lost at 4-fold
diluted IL-4 in the absence of Notch signaling and the majority of cells were Gata3- at
lower concentrations (Figure 3-8B). Conversely, Foxp3 expression was more readily
induced at higher concentrations of IL-4 and accumulated as a Foxp3+Gata3- population
at the lowest concentrations, whereas the majority of Foxp3+ cells in control cultures
retained Gata3 expression (Figure 3-8B). Altogether these data indicate that Notch
signaling plays a critical role in stabilizing inflammatory Th cell differentiation by
antagonizing Treg differentiation in the presence of a complex cytokine milieu.
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Figure 3-8: Notch is a critical regulator of the Th17-Treg and Th9-Treg axes.
WT CD4+ T cells were stimulated as described and then cultured in a titration
series of four-fold serially diluted (A) IL-6 or (B) IL-4 and constant TGFβ in the
presence of either DMSO or GSI. After 5 days, cells were analyzed by intracellular
flow cytometry.
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Discussion
The Notch pathway frequently functions as a potent instructional pathway, classically
involved in bipotential fate decisions during development(Radtke et al., 2010). We
recently reported a role for Notch as an unbiased amplifier of multiple inflammatory Th
cell subsets, which is mechanistically distinct from its instructional role during T lineage
development before β-selection. Here we tested the hypothesis that Notch signaling
plays unique roles pre- and post-β-selection by expressing a constitutively active form of
Notch1 under the control of CD4-Cre. Unlike studies in which activation of Notch
signaling prior to β-selection resulted in T lineage instruction and drove T-ALL onset,
CD4-Cre ICN1 mice fail to develop leukemia and instead exhibit a lethal
autoinflammatory disorder mediated by a cell autonomous increase in Th1, Th2, and
Th17 differentiation. Additionally, our studies revealed a novel role for Notch signaling in
inhibiting Treg differentiation, by desensitizing activated CD4+ T cells to TGFβ.

The role of the Notch pathway as an instructor of normal and malignant T lineage
development is well known. Constitutive activation of Notch signaling is sufficient to
launch the T lineage program and induce leukemia in multiple models. Early studies
showed that retroviral expression of ICN1 in bone marrow progenitors resulted in de
novo T cell development outside of the thymus, at the expense of B cell development,
and ultimately T-ALL onset(Allman et al., 2001; Pear et al., 1996; Pui et al., 1999).
Conversely, without the instructive signals derived from Notch, T lineage development
fails to occur and B cell development can be observed in the thymus(Han et al., 2002;
Maillard et al., 2004; Radtke et al., 1999). Even after progenitors commit to the T
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lineage, enforced Notch signaling has the capacity to instruct a T-ALL program.
Expression of ICN1 using Lck-Cre, which is active prior to β-selection, results in
thymocyte expansion and drives T-ALL, while Lck-Cre x ICN3FL/FL mice similarly exhibit
increased thymocyte cellularity and T-ALL(Bellavia et al., 2000; Bellavia et al., 2002;
Deftos et al., 2000; Robey et al., 1996).

Our work using CD4-Cre x ICN1FL/FL mice now illustrates that these potent pro-leukemic
and instructional activities exerted by the Notch pathway at early stages of T lineage
development are lost after β-selection. Cre expression in this model begins after TCRβ is
expressed and peaks between the DP and SP stages of thymocyte development(Shi
and Petrie, 2012; Wolfer et al., 2002). Although all NIC mice analyzed in our study died
by 6 months after birth, this was due to a severe autoinflammatory disorder and none of
the mice developed leukemia. This finding is consistent with the observation that
inactivation of the Notch pathway in the T cell compartment after β-selection results in no
gross developmental defects and only yields phenotypes after peripheral T cells are
activated(Amsen et al., 2004; Maillard et al., 2004; Tu et al., 2005; Wolfer et al., 2002).

Similar gain-of-function studies have also been used to contend that Notch instructs
fates at later stages of T cell development. Retroviral expression of ICN1 in activated T
cells was suggested to selectively instruct the differentiation of individual Th cell subsets.
Enforced Notch activation in Th cells has been shown to solely instruct Th2
differentiation in multiple studies, while other groups have reported the selective
induction of IFNγ and Tbet by intracellular forms of Notch(Amsen et al., 2007; Amsen et
al., 2004; Fang et al., 2007; Maekawa et al., 2003; Minter et al., 2005). While our in vivo
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model of Notch activation agrees insofar that Notch signaling can support both Th1 and
Th2 differentiation, we fail to see any selectivity or instruction by Notch signaling with
regard to cytokine production by Th cells. Instead, we observe a concurrent and cellautonomous increase in Th1, Th2, and Th17 differentiation, consistent with our
molecular and loss-of-function findings that the Notch pathway simultaneously amplifies
the differentiation of multiple inflammatory Th cell subsets(Bailis et al., 2013). It is likely
that the discrepancies between our in vivo study and previous in vitro studies using ICN
stems from the fact that Notch signaling acts to sensitize activated T cells to exogenous,
inflammatory differentiating cues(Bailis et al., 2013). Thus, the manner in which an in
vitro differentiation system is established can yield seemingly instructive phenotypes for
ICN expression if these conditions have an inherent bias toward Th1 or Th2
differentiation. Indeed, in the same study that ICN1 was shown to instruct Th2
differentiation in vitro, loss of Gata3 in this model resulted in Th1 “instruction” by
ICN1(Amsen et al., 2007). Finally, these new gain-of-function findings exclude the
possibility that our loss-of-function studies masked a dose-dependent instructional role
for Notch signaling in Th cell differentiation and show that the Notch pathway is both
necessary and sufficient in potentiating multiple fate outcomes in the peripheral T cell
compartment, under weak differentiating conditions.

In addition to simultaneously promoting differentiation of multiple inflammatory Th cell
subsets, our study also evinces a new role for the Notch pathway in destabilizing Treg
differentiation. In keeping with a model in which Notch signaling functions as an
integrator of exogenous cues, we find that Notch acts to desensitize activated T cells to
environmental TGFβ during the initiating of Treg differentiation, but fail to see this effect
after Foxp3 is already expressed. Moreover, our mixed bone marrow chimera
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experiments indicate this is a cell-autonomous function. Nonetheless, previous studies
have argued for a positive regulatory role for Notch in Treg differentiation. In one study,
inhibition of Notch signaling using either GSI or an antisense transgene was suggested
to impair Treg differentiation(Samon et al., 2008). The differences between our findings
may be accounted for by the high levels of ICN observed in the other study’s GSI-treated
and Notch1-antisense samples. Additionally, our studies used naïve CD4+ T cells and
antigen presenting cells for our in vitro assays, in contrast to the use of total CD4+CD25cells and plate-bound antibody. In another study, Lck-Cre x ICN3FL/FL mice displayed a
substantial expansion of CD25+Foxp3- cells, but also exhibited a roughly three-fold
expansion of CD25+Foxp3+ cells with enhanced suppressor function. This expanded
Treg population is lost when ICN3-transgenic mice are crossed to Ptcra-/- mice,
indicating that these cells are likely naturally occurring Tregs and may suggest distinct
roles for Notch in thymic and peripheral Treg populations (Anastasi et al., 2003;
Campese et al., 2009). It is also worth noting that autoinflammatory disorders have not
been observed in T cell-specific conditional loss-of-function Notch models, as would be
predicted if Treg differentiation were impaired, and instead defects in inducing
inflammation are present(Radtke et al., 2013). Our studies are consistent with a role for
Notch as a negative regulator of Treg differentiation as autoinflammation results from
Notch1 gain-of-function.

In summary, our gain- and loss-of-function data evince a role for Notch as an unbiased
integrator of exogenous differentiation cues that act to sensitize T cells to inflammatory
signals and desensitize T cells to regulatory signals. This model is consistent with our
observation that the Notch pathway is a key regulator of the balance of regulatory and
inflammatory Th cell populations that are activated under complex cytokine mixtures,
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such as Th9 and Th17 differentiation. While a role for Notch in Th9 and Th17
differentiation has been previously reported (REFS), we find that loss of Notch signaling
not only destabilizes the differentiation of these subsets, but also enhances Treg
differentiation under conditions that otherwise would not favor this population(Elyaman et
al., 2012; Keerthivasan et al., 2011; Mukherjee et al., 2009). Indeed, Notch inhibition
concurrently results in impaired Th17 differentiation and enhanced Treg differentiation in
experimental autoimmune encephalomyelitis(Bassil et al., 2011; Keerthivasan et al.,

2011; Sandy et al., 2013). Moreover, inhibiting the Notch pathway has also been found
to simultaneously impair Th1, Th2, and Th17 differentiation while enhancing Treg
differentiation in a mouse model of graft-versus-host disease(Tran et al., 2013; Zhang et
al., 2011). Our findings now provide a mechanistic basis for these observations and
further highlight the utility of Notch inhibition as a therapeutic for inflammatory disorders.
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CHAPTER 4: Discussion and Future Directions
Lineage development is directed both by extrinsic environmental cues, in the form of
soluble mediators and cell-surface molecules, and intrinsic regulation of transcription at
the level of transcription factors, chromatin conformation, and epigenetic modification.
The context and manner in which a developing cell integrates this wide range of inputs
ultimately dictates the fate choices that the cell will make. Within the hematopoietic
system, T lineage development is one of the best characterized developmental
pathways, with both extrinsic and intrinsic mediators known for multiple well defined
developmental stages (Rothenberg et al., 2010). Yet despite our wealth of knowledge on
the development of this essential immune population, we have little understanding of
how many of the intrinsic mediators of T lineage development exert distinct functions at
multiple stages in the T lineage progression. For example, Gata3 is understood to be
essential for early T lineage commitment of all αβ-T cells, the induction of CD4+ SP (but
not CD8+ SP) thymocyte development, and finally the selective instruction of Th2
differentiation at the expense of other Th cell fates (Rothenberg and Scripture-Adams,
2008). Moreover, Gata3 has been found to regulate distinct sets of transcriptional targets
at each of these stages, an observation that cannot solely be explained by transcription
factor concentration and/or motif binding affinity (Wei et al., 2011). Here I present
findings that illustrate how the Notch pathway similarly exerts unique functions at early
and late T cell development. While Notch signaling displays strong instructional capacity
prior to the β-selection checkpoint, I find that Notch signaling lacks this ability thereafter
and instead acts to potentiate multiple Th cell fates by sensitizing activated CD4+ T cells
to exogenous differentiating cues, thus functioning as a signal integrator. The
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implications for these findings on Notch signaling in T lineage development, T-ALL
transformation, and development of non-T populations within the hematopoietic system
are discussed in this chapter.

Two paradigms of Notch signaling, one lineage
The Notch pathway is a potent lineage instructor during early hematopoietic
development. Enforced Notch signaling in bone marrow progenitors is sufficient divert
cells with lymphoid potential away from the B lineage and launch the T lineage program,
while loss of Notch signaling renders the thymus barren of its ability to foster T lineage
development (Allman et al., 2001; Pear et al., 1996; Pui et al., 1999; Radtke et al.,
1999). Even in the absence of an ICN transgene, Notch ligand stimulation is sufficient to
divert myeloid progenitor cells into the T lineage (Chi et al., 2011). This instructive
capacity of Notch is so pronounced that T lineage cells develop outside of the thymus
when signaling is constitutively on, illustrating that Notch signaling itself, not other
components of the thymic microenvironment, dictates entry into T development.

Mechanistically, Notch signaling is understood to instruct T cell development by
coordinating the expression of genes that directly program the T lineage identity as well
as genes that function to restrict alternate fates. The TCR is fundamental to the T cell
identity and core function and the Notch pathway is understood to regulate several key
stages of its assembly. As discussed in Chapter 1, Notch signaling is essential for the
first stages of TCR assembly. Notch both directly and indirectly regulates Ptcra, by
binding to the Ptcra promoter to drive transcription and by promoting the splicing of
Ikaros isoforms that lack DNA binding capacity (Bellavia et al., 2007; Reizis and Leder,
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2002). Moreover, RBPJ-deficient thymocytes display impaired TCRβ rearrangement,
suggesting that Notch regulates pre-TCR signaling at the level of both pTa and TCRβ
(Ciofani et al., 2006; Wolfer et al., 2002). In addition to regulating TCR assembly, Notch
signaling controls the expression of three of the most important T lineage commitment
factors: Gata3, Tcf7 (Tcf1), and Bcl11b (Rothenberg, 2012; Rothenberg et al., 2010).
All three of these factors are required for early T development and, in addition to
regulating a network of key T lineage identity genes, Tcf1 and Bcl11b act to restrict
alternate lineage programs. While Bcl11b limits NK and myeloid potential and terminates
gene expression associated with the stem/progenitor program, Tcf1 plays an important
role in restraining B cell development (Ikawa et al., 2010; Li et al., 2010a; Li et al.,

2010b; Weber et al., 2011). Furthermore, the canonical Notch target Hes1 has recently
been shown to constrain myeloid development within the thymus (De Obaldia et al.,
2013). Finally, Notch further promotes T lineage development by providing a growth and
survival advantage for T committed cells, via the direct regulation of two essential
thymocyte survival factors: Il7ra and Myc (Gonzalez-Garcia et al., 2009; Wang et al.,
2014; Weng et al., 2006). Thus, the Notch pathway instructs T lineage development by
promoting the assembly of the TCR, launching the core T lineage transcriptional
network, restricting alternate fates, and promoting the outgrowth of committed cells.

In contrast to the multilayered instructional capacity of Notch during early T
development, the work presented in Chapters 2 illustrates the lack of instruction by the
same pathway during late-stage T development. Like its regulation of T lineage defining
factors such as the TCR and the core T lineage transcriptional network, Notch signaling
similarly regulates the signature effector proteins and transcription factors of Th cells.
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However, instead of supporting a single Th cell subset, Notch simultaneously binds and
directly regulates Il4, Ifng, Il17a, Gata3-1a, Tbx21, and Rorc, early after T cell activation.
This activity appears to only be essential when environmental differentiation cues are
limiting, as Th cells can differentiate successfully in the absence of Notch at high
cytokine concentrations, whereas the requirement for Notch signaling in T lineage entry
is absolute. The gain-of-function studies presented in Chapter 3 further illustrate the
Notch pathway’s ability to promote the differentiation of multiple Th cell populations in
vivo, in contrast to the selective induction of T cell development when Notch signaling is
enforced prior to β-selection (Allman et al., 2001; Pear et al., 1996; Pui et al., 1999).
Insofar as the Notch pathway restricts alternate fates during Th cell differentiation, Treg
induction is destabilized in the face of constitutive Notch signaling, however residual
Treg differentiation capacity persists. This is in contrast to the complete loss of B cell
potential in ICN1 transduced bone marrow cells, suggesting that, while the Notch
pathway does retain properties of lineage restriction in peripheral T cells, this activity is
modest compared to its function in thymocyte development (Pui et al., 1999).

Finally, the extent to which Notch signaling provides a survival or proliferative advantage
to signal receiving cells during Th cell differentiation remains less clear. Dll4 stimulation
can enhance T cell survival following activation and mice deficient in components of the
Notch pathway display decreased proliferation and survival following immunization with
adjuvant and peptide (Helbig et al., 2012). Additionally, another report described an
important role for Notch signaling in promoting T cell proliferation via Myc, downstream
of the TCR (Guy et al., 2013). While these two studies suggest that Notch can play a
role in peripheral T cell growth and survival, other loss-of-function Notch studies in
peripheral T cells have reported no effect of Notch on T cell proliferation following
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activation, suggesting that Notch effects on these processes are likely to be context
dependent, much like the relationship between Notch and cytokines (Amsen et al., 2004;
Bailis et al., 2013; Minter et al., 2005; Tu et al., 2005). Nonetheless, both these studies
failed to report any selective preference of Notch signaling in promoting the survival of
individual Th cell subsets, suggesting that while the pathway may similarly regulate
growth and survival during early and late T lineage development, this activity does not
impart any instructive capacity to Notch during Th cell differentiation as it does during T
lineage entry.
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Figure 4-1: Two paradigms of Notch signaling. (A) Notch can function as a
lineage instructor during development, as seen in early thymocyte development.
The Notch transactivation complex is capable of binding and directly activating
genes that define lineage identity (i.e. Tcrb), genes that govern lineage commitment
(i.e. Bcl11b), and genes the control cells survival and proliferation (i.e. Myc). In turn,
lineage commitment factors suppress alternate fate potentials and survival factor
promote the outgrowth of committed cells, enforcing lineage identity. (B) Notch also
has the capacity to function as an integrator of exogenous differentiating cues, as
seen in Th cell differentiation. In the absence of other activating signals, the Notch
transactivation complex binds to lineage commitment and identity genes for multiple
lineage programs (i.e. Gata3, Tbx21, and Rorc) in an impartial manner, sensitizing
them to transactivation by other pathways. Upon receiving lineage-biasing signals,
transcriptional activators are recruited to genes that promote the differentiation of a
single lineage (i.e. Tbx21 only) by synergizing with Notch complexes at those sites.
Subsequently, the activated lineage commitment factors repress transcription at loci
for alternate lineages, reinforcing differentiation. During this process, Notch also
provides cell survival and growth signals to all differentiated cells, regardless of
lineage. In this setting, Notch remains capable of synergizing with new activating
signals that may re-differentiate this cell to an alternate fate.
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Rather than supporting an instructional model, the data presented here suggest the
Notch pathway acts to integrate a wide array of environmental cues into a coherent
transcriptional program. I have shown this at the level of cytokine sensitization and the
ability of Notch to synergize with components of these pathways at Th cell signature
gene loci, however data from other groups indicate that Notch can similarly integrate
signals from other pathways. As mentioned above, Notch signaling can act directly
downstream of the TCR. Signal transduction downstream of the TCR is mediated via the
phosphorylation of multiple conserved motifs (ITAMs) found on CD3 proteins (Love and
Hayes, 2010). Upon T cell activation, Guy and colleagues detected the recruitment of
Notch1 and components of the Notch cleavage machinery to the TCR, in a manner
dependent on high ITAM multiplicity. Given Notch signaling was also found to induce
Myc transcription and Myc expression was found to be reduced in cells with low ITAM
multiplicity or activated with weak TCR agonists, it was postulated that Notch signaling
directly couples proliferation and cell growth to TCR signal strength, and thus functions
as a rheostat for activation as dictated by antigen affinity (Guy et al., 2013). In addition to
acting directly downstream of the TCR, Notch signaling has also been suggested to
interact with other critical T cell activation pathways. Notch inhibition after T cell
activation impairs sustained activation of NF-κB and ICN1 may even directly interact with
components of NF-κB signaling. Moreover, Notch was found to cooperate with NF-κB
and regulate transcription at the Ifng promoter, illustrating its ability to integrate signals
from other pathways to mediate transcription of key T cell effector genes, much like we
observed for Notch and Tbet (Shin et al., 2006). Similarly, Smad3 directly interacts with
Notch1 and the two factors have been shown to cooperatively promote Il9 transcription
(Elyaman et al., 2012). Notch inhibition is also associated with a hyporesponsive
phenotype in CD4+ and CD8+ T cells from a mouse model of GvHD. These cells display
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decreased NF-κB and Ras/MAPK signaling and increased expression of negative
regulators of T cell activation, such as Dgka, Cblb, and Pdcd1, suggesting that Notch
signaling may act as a global integrator of activating signals (Sandy et al., 2013). While
Notch signaling has been found to interact with these pathways and others (such as
PI3K, Hedgehog, Wnt, and mTOR) in cancer and other cell types, the extent to which
Notch collaborates with the downstream transcriptional effectors from these networks in
activated T cells has not been evaluated and is an area of investigation for future studies
(Aster et al., 2011; Takebe et al., 2011).

Although this thesis reports findings indicative of a non-instructional role for Notch during
Th cell differentiation, this observation has only been made at the population level. Our
ChIP and GSI-washout data demonstrate that Notch can bind and directly regulate the
signature cytokine and transcription factor genes for Th1, Th2, and Th17 cells, but they
do not prove that this occurs simultaneously in the same cell. It remains possible that at
the single cell level, the Notch complex may display Th cell type specific activity, such
that Notch only binds to Ifng and Tbx21 in cells initiating Th1 differentiation, but not in
cells that have begun Th2 or Th17 differentiation. While this would still entail the Notch
pathway’s involvement in the differentiation of multiple populations from the same
progenitor, in contrast to thymocytes, it would be more consistent with what has been
observed for Notch in earlier stages of development: Notch selectively regulates celltype defining genes in individual cells, these targets (e.g. Tbet) coordinate core
transcriptional networks and restrict alternate fates, and Notch then selects for
differentiated cells by promoting growth and survival. Single-cell array or RNA-seq
studies performed on GSI-washout samples will go a long way to addressing this,
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however until ChIP technology becomes reliable in resolving transcription factor binding
at the single-cell level, these questions will likely remain difficult to directly address.

Implications for Notch signaling and T-ALL
The gain-of-function studies performed in Chapter 3 not only highlight a switch in Notch
instructional activity during normal development, before and after β-selection, but also
demonstrate a striking and concurrent switch in Notch oncogenic activity in promoting
malignant development. Multiple studies have shown that activation of Notch signaling
before β-selection, either using retroviral transduction or Lck-cre, results in highly
penetrant, rapid onset, and lethal T-ALL (Allman et al., 2001; Bellavia et al., 2000;
Bellavia et al., 2002; Deftos et al., 2000; Pear et al., 1996; Pui et al., 1999; Robey et al.,
1996). The data in Chapter 3 show that activation of Notch after β-selection, using CD4cre, fails to result in T-ALL and instead promotes the differentiation of multiple
inflammatory Th cell subsets, while destabilizing Treg development (Figure 4-2). These
findings raise fundamental questions about the mechanisms Notch signaling utilizes to
induce T-ALL.
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Figure 4-2: Notch signaling mediates distinct functions pre- and post-βselection. Prior to β-selection, Notch signaling is a robust instructor of cell fate.
Activated Notch signaling instructs T lineage development at the expense of B cell
development, and hyper-activation of the pathway diverts progenitors into a
malignant developmental pathway. After β-selection is completed, Notch signaling is
turned off for the duration of thymic development. If Notch signaling is enforced
during this period, it is incapable of launching a T-ALL program. Instead, maturing T
cells readily activate and differentiate into multiple inflammatory Th cell subsets that
in turn promote autoinflammation. Similarly, when Notch signaling is naturally
initiated after a naïve CD4+ T cell becomes activated, the pathway acts to integrate
environmental differentiation cues in a manner that sensitizes activated cells to
inflammatory Th cell differentiation and destabilizes Treg differentiation.
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Notch is thought to promote T-ALL onset through its ability to regulate multiple prosurvival and pro-proliferative pathways. Among these genes, c-Myc has been identified
as the critical Notch target in T-ALL, both necessary and sufficient for Notch driven
leukemia (Palomero et al., 2006; Sharma et al., 2006; Weng et al., 2006). Additionally,
Notch signaling has been shown to regulate the NF-κB and AKT pathways to promote
malignancy, though neither is sufficient for T-ALL (Landor et al., 2011; Lee et al., 2012;
Palomero et al., 2007; Vilimas et al., 2007). One possible explanation for the inability of
hyper-active Notch signaling to induce leukemia after β-selection is that one or more of
these critical T-ALL targets are inaccessible to Notch at later stages of development. In
particular, we have identified a long-distance, Notch dependent Myc enhancer that is
active in both in DN3 thymocytes and T-ALL and required for Notch activation of Myc (in
submission). It will be interesting to test whether Notch can still occupy this element,
whether the enhancer continues to loop to the Myc promoter, and/or whether this
enhancer remains active after β-selection. In addition to local studies at the Myc
enhancer, ChIP-seq analyses for Notch1 and RBPJ comparing ICN1 transduced bone
marrow progenitors and DN3 cells from Lck-cre x ICN1FL/FL mice to DP and peripheral
CD4+ and CD8+ cells from CD4-cre x ICN1FL/FL mice will go a long way to clarifying Notch
target accessibility before and after β-selection. Combining this approach with RNA-seq
and ChIP-seq for various histone modifications in the above populations versus control
cells (i.e. Lck-cre x ICN1FL/FL DN3 cells versus Lck-cre x YFPFL/FL DN3 cells) will help
resolve the network of genes that the Notch pathway is capable of reprogramming at
multiple stages of development, providing functional relevance to Notch1 and RBPJ
ChIP-seq findings.
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Outside of target accessibility, another potential explanation for the dichotomy observed
in Notch signaling’s oncogenic potential during T lineage development is that obligate
co-factors are only present prior to β-selection. Between the DN2 and DN3 stages, the
transcription of many stem/progenitor legacy genes is extinguished, a large portion of
which have known oncogenic roles (Rothenberg et al., 2010). Of particular importance,
TAL1 mutations occur in approximately 60% of T-ALL cases and its expression is
markedly downregulated in early thymocyte populations, along with its binding partners
LMO1 and LMO2. Together, TAL1 and LMO proteins are understood to synergistically
cooperate to promote T-ALL, if their expression is sustained (Chervinsky et al., 1999;
Larson et al., 1996; Ono et al., 1997; Rothenberg et al., 2010; Van Vlierberghe and
Ferrando, 2012). Notch1 mutations spontaneously occur in TAL1/LMO driven T-ALL
mouse models, suggesting that the TAL1/LMO pre-leukemic thymocyte population is a
highly permissive setting for oncogenic Notch (O'Neil et al., 2006). A recent and elegant
study using cell competition to drive the first and only spontaneously occurring T-ALL
model in WT thymocytes not only recapitulates the mutations and oncogenic progression
found in human T-ALL, but also clearly illustrates that Notch mutations occur secondary
to sustained TAL1/LMO expression (Martins et al., 2014). Together these findings
suggest that Notch signaling may only be able to transform pre-leukemic populations,
which is most commonly established by TAL1/LMO, and the factors needed to create
this pre-leukemic state may only be expressed prior to β-selection.

CRISPR technology now enables us to rapidly model and study complex transgenic
combinations and could be utilized to test this hypothesis. Generation of Lck-cre x
Tal1FL/FLICN1FL/FL mice, such that Tal1 is deleted in DN2 cells and ICN1 is expressed,
should reveal whether or not the TAL1 complex is necessary for transformation by
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Notch. In a converse experiment, CD4-cre x tgTal1FL/FLtgLmo1FL/FLICN1FL/FL mice could
also be generated, such that TAL1, LMO1, and ICN1 are constitutively expressed after
β-selection, and would test the hypothesis that ICN1 fails to transform T lineage cells
later in development due to the lack of stem/progenitor legacy factors needed to
establish a pre-leukemic population. Although the mechanism responsible for the switch
in the Notch pathway’s oncogenic potential during T cell development remains unclear,
the findings presented in this thesis provide the framework needed to address these
questions in the future.

Revisiting the linear instruction model of Th cell differentiation
As discussed in Chapter 1, research over the past decade has increasingly challenged
Mossman and Coffman’s Th1/Th2 paradigm and the linear instruction model. The
identification of non-classical subsets such as Th17 and Treg cells, as well as the
putative Th9 and Tfh populations, and the observation that Th cells can interconvert has
not only invalidated a simplified bipotential model, but also directly questions whether Th
cell subsets represent true lineages defined by rigid programs. While different cytokines
clearly play a role in patterning and stabilizing individual Th cell programs, research has
often overlooked the existence of a core network of activating signals shared by all Th
subsets, derived from the TCR, costimulation, and as presented in this thesis, Notch
receptors, as the linear instruction model discounts viewing Th cells as a single
population. Researchers have attempted to apply the linear instruction model to all three
of these pathways, however TCR, costimulation, and now Notch signaling have all been
shown to influence the differentiation of multiple subsets in highly context dependent
manner, rather than displaying any instructive capacity. From this perspective, it may be
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more appropriate to view Th cells as a single lineage with the capacity to flexibly adopt
multiple functional modules that form semi-stable effector states (Figure 4-3).
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Figure 4-3: Hypothetical “modular” model of Th cell differentiation. When a naïve T
cell sees its cognate antigen on an MHC-II-bearing antigen presenting cell (APC), it
receives signals through a core Th cell signaling network consisting of the IL-1R, costimulatory receptors, the TCR, and Notch receptors. Together, the terminal
transcriptional effectors of these pathways construct a core platform of epigenetic
architectures and transcription factor complexes, such that the cell is receptive to
integrate unique signals from the given inflammatory environment. Shown is a
hypothetical Th cell response during helminth infection. Signals derived from invading
parasites are integrated into the core Th signaling platform and activate an anti-helminth
Th cell response (classically Th2). Gata3 and other transcriptional effectors activate a
modular network of transcriptional and epigenetic modifications that stabilize a Th2-like
phenotype. Depending on other signals received by these cells, they may either activate
a program that homes them to secondary lymphoid organs via a Bcl6-orchestrated
network, or traffic to the site of inflammation using a Blimp1-dependent effector module.
During the course of infection, these peripheral effector Th2-like cells may be exposed
to factors that license the production of auxiliary cytokines, such as IL-9, and these cells
may further be stimulated to turn on a Foxp3-regulated regulatory T cell transcriptional
module to further tailor their function. If a secondary infection occurs, these peripheral
Th2-like effector cells may adopt additional pathogen-specific programs, such as an
anti-viral Th1 module, that enables these cells to participate in complex immune
responses. Finally, some of the cells operating both a Th2-like and a Tfh module will
turn off their anti-helminth response, while maintaining the Bcl6-governed module, and
become central memory cells.
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Recent studies looking at the epigenetics of lineage differentiation highlight how Th cell
subsets are better represented as a single lineage with a large common regulatory
network rather than multiple distinct populations. A seminal epigenetic study looking at
global histone modifications in the various Th cell subsets found that few, if any, unique
epigenetic architectures existed amongst the individual Th cell subsets. Only 3-7% of
H3K4me3 labeled genes, denoting primed or active promoters, were unique to Th1, Th2,
Th17, or Treg cells, with these subtypes diverging by 5-10% in terms of H3K27me3
labeling, denoting primed or silenced genes. By comparison, thymus-derived natural
Tregs diverged by 28% and 22% for H3K4me3 and K3K27me3 from the other Th cell
populations, suggesting that differentiated Th cells are more similar than different, even
when compared to a closely related population. Moreover, the signature genes for
alternate Th cell programs were held in a poised chromatin conformation, indicating that
these loci could readily be expressed upon stimulation. This is distinct from the loss of
gene poising of lineage-specific factors during the differentiation of bona fide
hematopoietic lineages (Cedar and Bergman, 2011; Wei et al., 2009). Outside of the
canonical signature genes (i.e. Ifng and Tbx21 for Th1, Il4 and Gata3 for Th2, etc),
global gene profiling revealed a high degree of similarity in Th cell transcription, even
with regard to the transcription of genes thought to be selectively associated with only
one Th cell subset (e.g. appreciable Il5 transcripts were observed in Th1, Th2, and Th17
cells) (Wei et al., 2009).

A more recent study analyzed enhancer usage amongst the different Th cells subsets
and once again found a remarkable amount of epigenetic homology amongst these
populations. Using p300 binding as a surrogate for enhancer usage, Vahedi and
colleagues found that unlike distinct lineages such as macrophages or embryonic stem
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(ES) cells, which respectively only shared ~10% and <1% of their enhancer usage with
differentiated Th cells, Th1 and Th2 cells shared 65% and 55% of their enhancer usage
together, despite these two cell types being considered mutually exclusive states with
distinct transcriptional profiles. Not only do these cells exhibit similarity in global
enhancer usage, but they also share a common transcription factor regulatory network.
Even when enhancers specific to either Th1 or Th2 cells were analyzed for transcription
factor motif enrichment, the top three motifs were shared by both subsets: AP1, RUNX,
and NFAT. This particular finding further highlights the usage of a common signaling
network by all Th cells, as AP-1 and NFAT are downstream effectors of TCR and costimulation, respectively. In addition to these core-signaling factors, the GAS-3 motif,
which is bound by STAT1 and STAT4, was found to be one of the most enriched motifs
at both Th1- and Th2-specific enhancers (Vahedi et al., 2012). While STAT1 and STAT4
are downstream of the Th1-associated cytokines IFNγ and IL-12, type-1 interferons can
also activate STAT1 and it is interesting to speculate that these data implicate this
important family of inflammatory mediators as a component of the core Th signaling
network. In contrast to the shared motifs used by Th1 and Th2 cells, even at subsetspecific loci, a similar motif enrichment analysis performed at the enhancers of B cells,
erythrocytes, CD4+ T cells, ES cells, and liver cells found almost no homology in
transcription factor motif enrichment (Heinz et al., 2010). Collectively, epigenetic and
transcriptional profiling of the Th cell subsets shows that, while these populations indeed
represent unique functional programs, they display a striking degree of homology that is
utterly lacking when similar analyses are performed on bona fide, distinct lineages.

Viewing Th cells as a single lineage with a broad shared signaling network not is only
more compatible with epigenetic and transcriptional data, but is also more in line with our
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current understanding of Th cell plasticity. In this context, the “master regulators” can be
understood to impart bundled and stackable effector properties. Tbet, Gata3, and Rorγt
may be better appreciated as pathogen-specific programs tailored to home effector cells
to the relevant tissue where they can properly eliminate invaders, rather than lineage
reprogramming factors. These pathogen-specific programs could be overlaid with a
regulatory program (Foxp3), a germinal center/central-memory program (Bcl6), a
peripheral tissue effector program (Blimp1), or licensed to produce additional accessory
cytokines (IL-9), in order to tailor nuanced local responses. Given unique classes of
pathogens require different immune responses and it is necessary to maintain a stable,
coherent response until a pathogen is cleared, it is not surprising that the pathogenprogramming factors (Tbet, Gata3, and Rorγt) tend to be expressed independently of
one another and we fail to observe the spontaneous introversion of Th cells in classic
infection models. Moreover, as Th cells have such a robust core signaling network, there
is a need for factors that permit T cells to efficiently adopt individual anti-pathogen
programs. In this light, the findings reported in Chapters 2 and 3 demonstrate that the
Notch pathway is a component of the core Th cell signaling network that allows for the
rapid diversion of an activated cell into one of these semi-stable, pathogen-specific
functional programs (Figure 4-4). Thus Notch is not essential for differentiation if
exogenous factors can robustly activate these programs alone, but inhibition of Notch
signaling during immune responses with weak or complex inflammatory milieus results in
the marked destabilization of Th cell differentiation, as seen in a wide variety of models
(Billiard et al., 2012; Fang et al., 2007; Jiao et al., 2014; Park et al., 2013; Tran et al.,
2013; Zhang et al., 2011).
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While the classical linear instruction model remains useful for conceptualizing the unique
properties of each Th cell subtype, it is in inadequate for predicting the behavior of the
signaling molecules and transcription factors participating in Th cell differentiation, other
than those involved in cytokine signaling. By modeling Th cell differentiation as a single
lineage capable of adopting multiple, overlaid functional modules, there becomes less of
a need to understand how these programs are rigidly enforced and a greater need to
understand how the multitude of signals that activated T cells receive are coherently
integrated to give the illusion of distinct lineages. Moreover, increased emphasis is
needed to understand how exogenous factors modify the outputs derived from the core
signaling network, rather than looking for how these factors lead to a linear in-put/out-put
within a single signaling pathway.
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Figure 4-4: Notch and the hypothetical “modular” model. Notch acts to promote
the integration of inflammatory modules into the core Th signaling platform, while
destabilizing the integration of regulatory modules. When CD4+ T cells are
activated, the core Th signaling platform inefficiently integrates both inflammatory
and regulatory modules. When Notch signaling is engaged, inflammatory modules
are readily integrated, while regulatory modules are excluded. In contrast, when
Notch signaling is inhibited, inflammatory modules are poorly integrated and
regulatory modules are utilized.
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Applying the signal integration model of Notch to other developmental processes
It is not surprising that the first Notch-dependent phenotypes described were those
involved in fate choice decisions, as these phenotypes provided robust all or none
results in genetic studies (Guruharsha et al., 2012). However, recent work on Notch
signaling has highlighted how this classically instructive pathway can be involved in the
development of multiple closely related lineages in the hematopietic system. Innate
lymphocytes (ILCs) are an innate immune population that shares both functional and
developmental properties with T lineage cells. Not only are ILCs subfractionated using
identical functional criteria as Th cells (with ILC1s producing Th1-like cytokines, ILC2s
producing Th2-like cytokines, and ILC3s producing Th17-like cytokines), but they also
share some of the core T lineage transcriptional network. Gata3, Tcf1, and Notch
signaling have all been shown to play roles in ILC development and it has been
suggested that this implies an evolutionarily conserved transcriptional network shared
between ILCs and thymocytes (Tait Wojno and Artis, 2012; Yang et al., 2013). Notch
signaling is thought to be involved in both ILC2 and ILC3 development. Two different
populations of ILC3s, lymphoid tissue inducer cells (LTi) and IL-22 producing ILCs
(ILC22s), require Notch signaling during development and ILC2 development is similarly
dependent on Notch signaling both in vitro and in vivo (Cherrier et al., 2012; Lee et al.,
2011; Wong et al., 2012b; Yang et al., 2013). If one envisions that the role Notch plays in
ILC development occurs along similar lines as its unbiased role in Th cell differentiation,
then one would predict that Notch signaling does not instruct individual ILC subsets, but
rather allows for efficient differentiation and/or function of all three ILC subtypes when
conditions are otherwise not permissive. Notably, ILC22 development is only impaired in
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the lamina propria, but not the Peyer’s patches, in the absence of RBPJ, consistent with
the notion that the requirement for Notch may depend on whether the exogenous
differentiating cues present in a given environment are limiting, rather than an absolute
necessitation for the pathway (Lee et al., 2011). While it remains to be seen whether
Notch signaling is also involved in ILC1 development, future studies of Notch and ILC
biology should take caution in ascribing instructional activities to the pathway when an
unbiased, signal integrating model may be a more effective means of understanding how
Notch functions within this lineage.

In addition to ILCs, recent studies have also uncovered unappreciated roles for Notch
signaling in DC development and function. Though Notch signaling had previously been
implicated as an important factor in DC development, where it was thought to be
involved in the expansion of pre-DC populations, the extent to which it regulates multiple
subsets has only been revealed (Cheng et al., 2003). Studies have now implicated
Notch signaling in the development of conventional DCs, splenic CD8- DCs,
plasmacytoid DCs (pDC), thymic Thy1+ DCs, EsamHiCD11b+ DCs, CD11b+CD103+ DCs,
and even human DC populations (Caton et al., 2007; Ishifune et al., 2011; Lewis et al.,
2011; Li et al., 2008; Olivier et al., 2006; Zhou et al., 2009a). Moreover, the Notch
pathway is important in regulating cytokine and chemokine production in multiple DC
populations following activation (Bugeon et al., 2008; Gentle et al., 2012; Hu et al., 2008;
Perez-Cabezas et al., 2011; Svensson et al., 2010). Paralleling its activity in Th cell
differentiation, Notch signaling has also been suggested to regulate DC development
and function by integrating exogenous stimuli, including TLR ligands and IFN signaling
(Gentle et al., 2012; Hu et al., 2008; Svensson et al., 2010). Viewing the role of Notch in
DC biology as an integrator of exogenous signals, rather than a lineage instructor, not
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only is more consistent with the current literature, but also fits with our understanding of
DCs as a dynamic lineage that persists in a wide range of tissues and
microenvironments. In this manner, Notch signaling could be understood to allow DCs to
efficiently and robustly adapt to a given environment and adopt an appropriate function
and fate for a given immune response, even in the face of a complex inflammatory
milieu. Further highlighting the similarities in Notch function in Th cell and DC biology,
while Notch signaling has been implicated as an important regulator of inflammatory DC
function, inhibition of Notch signaling has been found to expand a population of DCs with
the capacity to induce Treg differentiation, leading to an accumulation of Tregs in vivo
(Billiard et al., 2012). Though this is only one report, it is tantalizing to speculate that the
Notch pathway functions similarly in both DCs and Th cells in order to coordinate
inflammation, at the expense of regulatory responses, thus resulting in the synergistic
induction of robust inflammatory responses. Taking this hypothesis further, it would also
predict that systemic inhibition of Notch signaling would be particularly efficacious in
resolving inflammation and promoting regulatory function, and indeed this phenomena
has been observed for models of arthritis, EAE, type-1 diabetes, and GvHD (Billiard et
al., 2012; Jiao et al., 2014; Park et al., 2013; Tran et al., 2013; Zhang et al., 2011).
Whether or not Notch plays a non-instructional role in other developmental processes
remains to be tested, but recent work on ILCs and DCs illustrates the utility of the signal
integration model in interpreting these findings and generating hypothesis for future
studies.
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Materials and Methods
Mice
ROSA26-DNMAML mice were previously described (Tu et al., 2005). C57Bl/6 mice were
obtained from the National Cancer Institute (Frederick, MD). ICN1 transgenic mice were
a kind gift from Douglas Melton (Harvard University, MA) and crossed with CD4-Cre
(Taconic, NY) or Foxp3-Cre (from Alexander Rudensky, at Memorial Sloan Kettering
Cancer Center, NY). Tbx21-/- mice were generously provided by John Wherry (University
of Pennsylvania, PA). YFP mice, Rag1 deficient mice, SJL mice and C57BL/6 were
obtained from Jackson Laboratories (Bar Harbor, ME). All mice were housed in specific
pathogen-free facilities at the University of Pennsylvania. Experiments were performed
according to the guidelines from the National Institutes of Health with approved protocols
from the University of Pennsylvania Animal Care and Use Committee.

TAT-Cre
Expression of TAT-cre was induced with IPTG in bacteria during log phase of growth at
37°C in the presence of chloramphenicol and carbenicillin. The Children’s Hospital of
Pennsylvania Protein Core carried out purification of TAT-Cre protein. 107 CD4+ T cells
from DNMAMLFL/FL or YFPFL/FL mice were MACS purified by positive selection with CD4
Microbeads (Miltenyi). Subsequently, cells were washed, resuspended in 1 ml serumfree OPTI-MEM (Life Technologies), and incubated with 1 ml of 100 mg/ml of TAT-Cre in
OPTI-MEM for 12 min at 37oC. Cells were then washed and cultured in IMDM (Life
Technologies) supplemented with 10% heat-inactivated FBS, 100 U/ml penicillin, 100
mg/ml streptomycin, 2 mM L-glutamine, 50 mM 2-mercaptoethanol, and 100ng/mL IL-7.
Twenty-four hours later, naïve YFP+ or GFP+ CD4+ T cells were FACS sorted
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Quantitative PCR
RNA was extracted using the QIAGEN RNeasy Mini Kit. cDNA was synthesized from
RNA with the Superscript II kit (Invitrogen). Transcripts were amplified with Sybr Green
PCR Master Mix (ABI) and quantitative PCR was performed on an ABI ViiA 7 Real-Time
PCR System. (Primers, Table S1)

Chromatin immunoprecipitation assays
Chromatin immunoprecipitation (ChIP) was performed as described previously (YashiroOhtani et al., 2009). Briefly, chromatin samples were prepared from fixed 6 million cells
and immunoprecipitated with rabbit immunoglobulin G (#sc-3888; Santa Cruz
Biotechnology, Santa Cruz, CA) or anti-Notch1 antibodies (Aster et al., 2000). Purified
DNA was subjected to real-time polymerase chain reaction (PCR) with primers flanking
RBPJ binding sites at Gata3-1a, Il4 HS5, IFNg CNS-22, or Tbx21 promoter (primers,
Table S2). CD4+ T cells from Notch1 null mice were used for an immunoprecipitation
negative control. Nanog was used as an internal negative control. The DNA quantity
recovered from each ChIP sample is shown as the relative value to the DNA input
sample.

Luciferase assay
Ifng luciferase constructs are described (Hatton et al., 2006). Constructs included a
reporter control (pGL3), the reporter plus a 468 bp Ifng minimal promoter (ProWT), the
minimal promoter construct containing a mutated T-box binding site (ProMT), the minimal
promoter construct with a WT Ifng CSN-22 upstream (ProWTCNSWT), the WT CNS-22
construct containing a mutated T-box binding site in the promoter region (ProMTCNSWT),
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the Ifng CNS-22 construct with the upstream CNS-22 T-box half-site mutated
(ProWTCNSMT1), and the Ifng CNS-22 construct with the downstream CNS-22 T-box halfsite mutated (ProWTCNSMT1). Point mutations to T-box binding sites in the Ifng promoter
were made using the Promega QuikChange Site Directed Mutagenesis Kit. Constructs
were sequenced to prove authenticity. 2 X 105 Jurkat cells were plated in triplicate and
transfected with 50 ng of the indicated promoter/reporter constructs, 25 ng pRL-TK, and
100 ng pcDNA-ICN1 or vector control using DMRIE-C (Invitrogen). Transfected cells
were cultured overnight and then stimulated for 4 hours with 20 ng/mL PMA and 200
ng/mL ionomycin. 2 x 104 U2OS cells were plated in triplicate and transfected with 50 ng
of the indicated promoter/reporter constructs, 10 ng pRL-TK, 10 ng pcDNA-ICN1 or
vector control, and 25 ng Mig-Tbet or vector control using FuGENE 6 (Promega). After
stimulation, firefly substrate activity was measured using Britelite Plus (PerkinElmer) and
renilla substrate activity measured using Stop & Glo (Promega). Firefly values were
normalized to Renilla and then all normalized values set relative to the pGL3 control
vector. All measurements were performed using a GloMax-96 Microplate Luminometer
(Promega).

In vitro T cell culture
Lymph nodes from WT mice were CD4+ MACS purified and then naïve CD4+ T cells
were FACS sorted. Naïve CD4+ T cells were co-cultured with irradiated, Thy1.2 depleted
splenocytes at a 1:5 ratio and stimulated using anti-CD3e (1 µg/mL), and anti-CD28 (1
µg/mL) mAb. Cells were cultured under either neutral (5 ng/mL IL-2, 20 µg/mL anti-IL-4,
and 20 µg/mL anti-IFNγ), Th1 (5 ng/mL IL-2, 5 ng/mL IL-12, and 20 µg/mL anti-IL-4),
Th2 (20 ng/mL IL-4, 20 µg/mL anti-IFNg, and 20 µg/mL anti-IL-12), Th9 (10 ng/mL IL-4
and 5ng/mL TGF-β), Th17 (20 ng/mL IL-6 and 5ng/mL TGF-β), or Treg (5 ng/mL IL-2
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and 5ng/mL TGF-β) culture conditions. For titration experiments, the conditions listed
above were used for 1x dilutions and all other dilutions were made from this stock. For
GSI experiments, cells were treated with either DMSO or 1 µM GSI.

Adoptive T cell transfer
Total T cells and non-T cells from spleen and lymph nodes of CD4Cre-YFP mice or
CD4Cre-ICN1 mice were purified and sorted with thy1.2 Abs. CD4 T cells and CD8 T
cells from spleen and lymph nodes of CD4Cre-YFP mice or CD4Cre-ICN1 mice were
positively selected with thy1.2 (30-H12) then sorted with anti-CD4 (RM4-5) and antiCD8a (53-6.7) 2 × 106 cells were transferred to B6 mice and frequency of Gr1+(RP68C5) and CD11b+ (M1/70) population in peripheral blood were analyzed after 4 weeks
of transfer.

Mixed bone marrow chimeras
5FU treated BM cells (BMCs) from WT (SJL) and CD4Cre-ICN1 mice were adoptively
transferred into sub-lethally irradiated (500 rad) Rag1 deficient mice with 1:1 mixture of
BMCs from WT (CD45.1; 2 × 106 BMCs) and/or CD4Cre-ICN1 (CD45.2; 2 × 106 BMCs)
mice. Recipient Rag1 deficient mice were treated with acidified, antibiotic water 1 week
before to 2 weeks after the irradiation and then switched to acidic water without
antibiotics for 4 weeks. Mice were analyzed 6 weeks after the transfer.

Measurement of cytokines
For intracellular cytokine staining, cells were restimulated, fixed, and stained as
described (Tu et al., 2005). Cells were stained with anti-CD4 (RM4-5, Biolegend), antiIFNγ (XMG1.2, BD), anti-IL4 (11B11, eBioscience), anti-IL17A (ebio17B7, eBioscience),
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anti-Tbet (eBio4B10, eBioscience), and anti-GATA3 (L50-823, BD). Cells were acquired
on a LSRII (Becton Dickenson) and data was analyzed with FlowJo (TreeStar). ELISA
was performed as described (Tu et al., 2005).

GSI-washout assay
WT CD4+ T cells were stimulated as above and 24 hours post-stimulation cells were
treated with either DMSO or GSI (1 µM) for 20 hours. Subsequently, T cells were CD4+
MACS purified and cells cultured in media containing cycloheximide (20 µg/mL) and
cells previously cultured DMSO were replated in DMSO and cells cultured in GSI were
either replated in 1 µM GSI or in DMSO for 4 hours. RNA was then harvested and
analyzed by qPCR.

T. muris infection and antigen
T. muris eggs were prepared as described (Tu et al., 2005). Mice were infected on day 0
with 150–200 embryonated eggs, and parasite burdens were assessed on day 21 after
infection. Mesenteric LN (MLN) cell suspensions were prepared and resuspended in
IMDM supplemented with 10% heat-inactivated FBS, 100 U/ml penicillin, 100 g/ml
streptomycin, 2 mM L-glutamine, and 50 M 2-mercaptoethanol. Cells were plated at 4 X
106 cells/well and cultured in the presence of anti-CD3e and anti-CD28 for 72 hours.
Levels of IL-4, -5, and -13 were assayed by sandwich ELISA. For histology, segments of
mid-cecum were removed, washed in sterile PBS, and fixed for 24 hours in
paraformaldehyde. Tissues were processed and paraffin embedded using standard
histological techniques. For detection of intestinal goblet cells, 5 µm sections were cut
and stained with hematoxylin and eosin or Alcian blue periodic acid Schiff. Analysis of
parasite- specific IgG1 and IgG2c production was performed by antigen capture.
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